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SUMMARY 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the 
selective death of motor neurons (MNs). The mechanism of MN demise, however, is poorly 
understood, and no effective treatment is yet available. In most cases ALS occurs sporadically, but 
10% of cases show a familial history and about 20% of these familial ALS (fALS) are caused by a 
mutation in the superoxide dismutase 1 (SOD1) gene. In particular, expression of the fALS-related 
SOD1(G93A) mutant in transgenic (Tg) mice closely resembles human disease. Recent research has 
found that mutant SOD1 (mSOD1) alters Ca2+ homeostasis in MNs and neighbouring astrocytes, 
thereby rendering MNs particularly vulnerable to the activation of a subset of harmful pathways. 
Such notions prompted us to compare local Ca2+ movements in spinal MNs and astrocytes from 
SOD1(G93A) and SOD1(WT) mice. To this purpose, we applied two different approaches. 
1. Analysis of local Ca2+ fluxes in MNs. 
i) We initially set the conditions for establishing MN-rich primary cultures from Tg mouse 
spinal cord; 
ii) we engineered and produced adeno-associated viral (AAV) vectors for the expression of 
cameleon Ca2+ probes targeted to different cellular compartments, under the control of a 
MN-specific (Hb9-derived) promoter; 
iii) we functionally tested and successfully used such Ca2+ probes for imaging Ca2+ 
oscillations in primary spinal cord MNs, demonstrating a specific expression  in MNs and a 
higher Ca2+ entry in the cytosol through AMPA stimulation in SOD1(G93A) MNs compared 
to controls. We demonstrated also that this probes can also be expressed in vivo in spinal 
cord MNs upon systemic administration to newborn mice.   
2. Analysis of local Ca2+ fluxes and related parameters in spinal astrocytes. 
Following the notion that astrocytes affect disease progression in fALS Tg mice, we have also 
undertaken a thorough comparative investigation of local Ca2+ homeostasis in primary spinal 
astrocytes from SOD1(G93A) and SOD1(WT) mice to determine if mSOD1 impairs astrocyte Ca2+ 
homeostasis. 
i) We initially set the conditions for the expression of locally targeted Ca2+ probes in 
primary spinal astrocytes; 
Summary 
VII 
 
(ii) following this approach, we provide evidence of altered Ca2+ homeostasis in different 
domains of SOD1(G93A) astrocytes following SOCE or exposure to ATP; 
(iii) in the attempt to mechanistically explain the observed Ca2+ phenomenology, we have 
undertaken (by classical biochemical and immunocytochemical approaches) a thorough 
comparative analysis of the expression of major Ca2+-transporting systems and other Ca2+-
related parameters in SOD1(G93A). 
In conclusion our data emphasize that the expression of SOD1(G93A) is strictly correlated to 
altered Ca2+ homeostasis in spinal cord astrocytes, thereby supporting the hypothesis that in ALS 
astrocytes convey deadly signals to MNs through Ca2+-dependent mechanisms. 
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RIASSUNTO 
La sclerosi laterale amiotrofica (SLA) è una malattia neurodegenerativa fatale caratterizzata dalla 
morte selettiva dei motoneuroni (MN). Il meccanismo principe a cui è dovuto il danno neuronale è 
sconosciuto e non esiste un trattamento efficace per la cura di questa terribile malattia. In molti casi 
la SLA si sviluppa in maniera sporadica mentre nel 10% dei casi presenta una caratteristica 
genetica. Circa il 20% di questi casi famigliari sono causati da una mutazione nel gene della 
superossido dismutasi 1  (SOD1). In particolare, topi transgenici (Tg) esprimenti la mutazione 
SOD1 (G93A), correlata alla SLA, sviluppano un fenotipo molto simile a quello umano. Recenti 
ricerche hanno constatato come la proteina SOD1 mutata sia in grado di alterare l’omeostasi del 
calcio nei motoneuroni e negli astrociti limitrofi, rendendo le cellule neuronali particolarmente 
vulnerabili all’attivazione di un insieme di meccanismi possibilmente tossici. Considerando un tale 
stato dell’arte il nostro obiettivo, in questo progetto, è quello di confrontare flussi locali dello ione 
Ca2+ in motoneuroni e astrociti primari derivanti dal midollo spinale di topi SOD1(G93A) e 
SOD1(WT).  
A questo scopo applicheremo due differenti approcci: 
1. analisi dei flussi locali di Ca2+ in motoneuroni primari: 
i) abbiamo ottimizzate le condizioni di estrazione e messa in coltura di motoneuroni primari 
dal midollo spinale di topi Tg; 
ii) abbiamo ingegnerizzato e prodotto vettori virali adeno associati (AAV) per l’espressione 
delle sonde  Ca2+ cameleon indirizzate a differenti compartimenti cellulari e sotto il 
controllo di un promotore motoneurone-specifico (derivato Hb9); 
iii) abbiamo testato funzionalmente e usato con successo le sonde per la misurazione delle 
variazioni di Ca2+ in MN spinali primari, dimostrando una espressione specifica della sonda 
nei MN e un alterato (incrementato) ingresso di Ca2+ nel citosol dopo stimolazione con 
AMPA nei MN SOD1(G93A) messi a confronto con il controllo. Abbiamo inoltre 
dimostrato che queste sonde possono essere espresse in vivo in MN del midollo spinale 
attraverso una somministrazione sistemica a topi neonati.   
2. Analisi dei flussi locali di Ca2+  e dei relativi parametri in astrociti spinali primari 
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Considerando il noto effetto di cross-talk degli astrociti sui motoneuroni nel progredire della 
malattia in topi con fenotipo SLA, abbiamo intrapreso una analisi comparativa dei flussi locali di 
Ca2+ in astrociti spinali primari derivanti da topi SOD1(G93A) e SOD1(WT).  
Al fine di determinare se la mutazione G93A fosse in grado di causare una variazione 
dell’omeostasi del Ca2+ si è proceduto nel seguente modo: 
i) inizialmente abbiamo settato le condizione per l’espressione in astrociti spinali primari di 
sonde Ca2+ indirizzate a specifici compartimenti cellulari; 
(ii) successivamente ci siamo focalizzati sulle misure di calcio fornendo la prova della 
presenza di flussi alterati di calcio in differenti domini cellulari di astrociti SOD1(G93A) 
dopo stimolazione del SOCE o recettori purinergici; 
(iii) nel tentativo di ipotizzare un possibile pathway che spiegasse la fenomenologia 
osservata abbiamo intrapreso una analisi comparativa (attraverso tecniche classiche di 
biochimica e immunocitochimica), in astrociti spinali primari SOD1(WT) e SOD1(G93A), 
dell’espressione dei principali sistemi di trasporto dello ione Ca2+ e  di altri parametri 
correlati. 
Concludendo i nostri dati enfatizzano che l’espressione di SOD1(G93A) è strettamente correlata 
con una omeostasi alterata dello ione Ca2+ in astrociti derivanti da midollo spinale, tutto ciò 
avvalora ulteriormente l’ipotesi di un cross-talk letale tra astrociti e motoneuroni attraverso un 
meccanismo Ca2+ dipendente. 
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1. INTRODUCTION 
1.1 Amyotrophic Lateral Sclerosis (ALS) 
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease or Charcot disease, is a 
fatal neurodegenerative disorder, with a predominance 1.2-1.5/1 male/female1, characterized by the 
selective loss of primary (cortical) and secondary (spinal) motor neurons (MNs). This selective 
death results in progressive weakness, difficulty in swallowing (dysphagia), breathing (dyspnea), 
atrophy of voluntary skeletal muscles, fasciculation and spasticity and in the end death. This 
neurodegenerative disorder is the most common amongst motor MN diseases and people of all races 
and ethnic background can be affected by ALS2. 
It’s only after the early stage of axonal dysfunction and retraction that the neuronal cell body 
becomes visibly abnormal and dies, as has been shown in animal models. The exact timing of these 
events in human ALS is less certain, but the rare post-mortem reports on patients who died very 
early in the disease confirm this sequence3. 
It’s known that 65% of general cases are classical (or spinal) forms where the firsts involved in the 
disease are limbs, while the remaining 35% are bulbar forms characterized by dysarthria and 
dysphagia. Usually the peak incidence of this disease is 50-70 years (juvenile ALS is rare) and the 
average age of death is 2-5 years after diagnosis4; in the majority of cases death occurs for 
denervation of the respiratory muscles and diaphragm5.  
Extensive studies carried out in recent years were not helpful to fully understand the mechanisms 
and the initial causes behind the neuronal degeneration that characterizes this disease. Indeed, 
despite intense effort, in literature and medicine no successful therapeutic strategy against this 
devastating disease are known, and as therapeutic option there is only a glutamate antagonist, 
benzothiazole riluzole, that increase survival of patients by few months slowing disease 
progression6. In the last few years, the understanding of some mechanisms of the disease 
underscored that ALS is probably part of a larger class of diseases, including Parkinson’s disease, 
Frontotemporal Dementia (FTD) and ataxias7–9. 
ALS disease is divided in two main classes: sporadic (s) forms (without an obvious genetic 
component) and familial (f) forms, where the first covers 90% of the total cases and the second one 
the remainder 10%10. Nevertheless, in last years many defective genes were found to be associated 
to both sporadic and familial forms. Different factors can also define the age of onset, severity of 
the symptoms and the variability of clinical manifestations. For example, a recent study proposed a 
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mathematical model describing ALS as a multistep process closely related to six genetic and/or 
environmental factors11. 
Most is still unknown, however, on environmental factors in disease aetiology, though several 
studies have highlighted their possible involvement in ALS, especially in sporadic forms12,13. 
Pesticide contamination, heavy metals (e.g., lead) in toxic concentrations14, smoking15 and alcohol 
consumption, and viral and fungal infections have been associated to ALS pathogenesis16. Familial 
forms are characterized by the presence of genes with mostly classical pattern of inheritance.  
The first gene, whose mutations were associated to fALS, was the one encoding superoxide 
dismutase 1 (SOD1) in 199317,18. This was also the first gene enabling the generation of a transgenic 
(Tg) mouse model (expressing the ALS-related G93A mutant of human (h) SOD1) closely 
recapitulating different aspects of the pathologic phenotype of fALS and sALS19. The generation of 
such an animal model has fostered experimental research, and increased knowledge on basic disease 
mechanisms. Subsequently, several ALS-associated mutations were identified in other genes, 
including those coding for the TAR DNA-binding protein 43 (TDP-43), and the RNA-binding 
protein “fused in sarcoma/translocated in liposarcoma” (FUS/TLS)20–22. More recently, a close link 
between intronic hexanucleotide (GC) repeat expansions in the chromosome 9 open reading frame 
72 (C9orf72) gene and both fALS and sALS has been established23,24.  
Together, the 4 genes described above account 60-80% of fALS cases. In particular mutations in 
C9orf72 cover most of familial form and the disease appears after the age of 40, while mutations in 
FUS/TLS are found in 10% of familial cases appearing before 40 years of age25 (Fig.1). 
 
Fig. 1 Timeline of gene discoveries in familial and sporadic ALS. Values represent the proportion of ALS explained by each gene in 
populations of European ancestry26. 
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All these genes, and the relative encoded proteins, take part to a very heterogeneous set of cell 
pathways, among which DNA/RNA processing, autophagy, vesicles transport, energy metabolism, 
cytoskeletal dynamics, apoptosis, oxidative stress scavenging, mitochondrial integrity, and more27 
(Fig. 2).  
 
Fig. 2 Main cellular functions where ALS causative or susceptibility genes are involved27. 
In spite of this heterogeneity of mechanisms, the symptoms and the progression of the illness are 
similar between the familial and sporadic forms of ALS. 
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1.2 Superoxide dismutase 1 (SOD1) 
SOD1 is a ubiquitous, predominantly cytosolic protein of 153 amino acids. It is an homo-dimeric 
Cu/Zn-binding enzyme (32KDa) encoded by the SOD1 gene, located on the chromosome 21, and 
composed of eight antiparallel β-barrels containing an intramolecular disulphide bond and a 
binuclear Cu/Zn site in each subunit (Fig.3). 
 
Fig. 3 A) Structure of human SOD1 protein. The beta barrel, the zinc loop and the electrostatic loop are shown in blue, green and red 
colour, respectively. The copper and zinc ions are shown as orange and blue spheres, respectively. B) ALS-related mutations in the 
SOD1 protein. The SOD1 mutations are shown as small spheres within the SOD1 protein monomer28. 
This protein is widely expressed and constitutes about 0.5/0.8% of soluble proteins in the brain. Its 
task is to catalyse the conversion of the superoxide anion in hydrogen peroxide and dioxygen  
through cyclic reduction and oxidation (dismutation) of Cu2+ to protect cells from reactive oxygen 
species (ROS) toxicity29. Mature protein is highly stable, but when it is in the metal-free and in 
disulphide-reduced form, SOD1 dysfunctions and tendency to oligomerization and aggregation is 
observed30,31. 
Approximately 10% of fALS and 3% of sALS cases are related to SOD1 mutations32–34. More than 
150 SOD1 mutations have been identified in ALS34, most of which are missense (involving at least 
75 aminoacids), while 12 mutations are nonsense or deletion mutations that produce truncated 
proteins. Among all fALS-associated mutations in the hSOD1 gene, the most common are G93A 
(that is also the most studied), A4V (the most prevalent (50%) in USA), H46R (the most prevalent 
in Japan), and D90A that represents 50% of fALS cases in Sweden and Finland28. 
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In Tg rodent models and human ALS cases SOD1-immunoreactive aggregates are evident by the 
time of disease onset and increase over time. Mutant SOD1 (mSOD1) displays also prion-like 
properties in vitro and in animal models as demonstrated by the evidence that mSOD1 has the 
ability to sequester wild-type (WT) proteins and seed their aggregation or misfolding acting as 
transmissible agents between cells (mSOD1 are found in medium from primary cultures of 
astrocyte)35. Moreover, selective expression of mSOD1 in MNs, astrocytes and microglia in vivo 
indicated that interaction between these cells is necessary to lead to MN degeneration and to the 
ALS typical phenotype, showing that MNs death is not cell autonomous36–40. 
Many lines of evidence have led to the conclusion that mutations in this protein cause ALS via an as 
yet unidentified toxic gain of function. Indeed, perturbations of different cellular systems have been 
implicated in ALS, but the correlation between the enzymatic activity of SOD1 and the clinical 
progression and disease phenotype is not yet clear. Moreover, the duration of the disease is similar 
for any given mutations32. 
mSOD1 impairs multiple cellular functions, including endoplasmic reticulum (ER) stress and Ca2+ 
overload, sensitizing MNs to apoptosis. Moreover, MNs of mSOD1 mice show early abnormalities 
in mitochondrial structure and physiology, such as dilated cristae and mitochondrial swelling, 
reduction in electron transport chain activity (especially in complex I and IV), reduced respiratory 
rate, mitochondrial membrane potential (Δψm) and adenosine triphosphate (ATP) generation. There 
is also in vivo evidence (based on the analysis of the cerebrospinal fluid of ALS patients) for 
excitotoxicity generated by excessive stimulation of postsynaptic glutamate receptors41–45. 
The most exploited mouse model of ALS is that based on Tg mice expressing the hSOD1(G93A) 
missense mutant. Mice hemizygous for hSOD1(G93A) transgene are viable and fertile, and exhibit 
a phenotype similar to human ALS: they become paralyzed in one or more limbs due to loss of 
MNs from the spinal cord. Tg mice have an abbreviated life span: 50% survive at 128.9+/-9.1 days. 
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1.3 Ca2+ homeostasis and neurodegenerative disorders  
The calcium ion (Ca2+) is the major intracellular messenger, mediating a variety of physiological 
responses to chemical and electrical stimulations. Therefore, cell Ca2+ concentrations must be 
tightly controlled in terms of both space and time, a task that is accomplished by several Ca2+ 
transporting and buffering systems. 
Excitable cells, and neurons in particular, are highly sensitive to subtle and transient rises of cellular 
Ca2+ concentrations that are primarily mediated by voltage-operated Ca2+ channels (VOCC) and 
receptor-operated Ca2+ channels (ROCC) of the plasma membrane (PM). Among the latter ones, 
ionotropic receptor channels for glutamate (a major excitatory neurotransmitter), including N-
methyl-D-aspartate (NMDA) and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) 
receptors, are particularly important for excitatory neurons in the central nervous system. Also the 
release of Ca2+ from the ER, by the activation of G-protein-coupled metabotropic glutamate 
receptors that stimulates the production of inositol trisphosphate (IP3) and downstream activation of 
Ca2+ channels in the ER (IP3- and ryanodine-receptors), is crucial for Ca
2+ metabolism. In parallel, 
the coordinated action of different extrusion systems, including the PM Na+/Ca2+ exchanger (NCX), 
and the PM- and sarco/endoplasmic reticulum-Ca2+ ATPases (PMCA and SERCA, respectively) 
ensures a fine and timely control of the cytosolic Ca2+ concentration (Fig. 4). 
 
Fig 4. Subcellular systems involved in the disruption of neuronal Ca2+ homeostasis in aging and neurodegenerative disorders. 
Oxidative stress causes peroxidation of lipids in the plasma membrane that impairs the function of ion-motive ATPases and glucose 
transporter proteins. This promotes membrane depolarization and cellular energy depletion, which results in excessive Ca2+ influx 
and accumulation of Ca2+ within the cell. Perturbed Ca2+ homeostasis may also result from endoplasmic reticulum stress and 
mitochondrial dysfunction. Abnormal aggregation of proteins contribute to the damage and dysfunction of Ca2+-regulating systems. 
Excessive amounts of Ca2+ within the neuron can cause dysfunction of a myriad of cellular processes. Calcium dependent proteases 
(CDPs)46. 
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In light of the above concepts, it is not surprising that Ca2+ metabolism plays a critical role in 
different fundamental functions of neurons, such as synaptic transmission, neurite outgrowth and 
synaptogenesis, neuronal plasticity, short- and long-term memory  and cell survival. Accordingly, it 
is not surprising that perturbed Ca2+ homeostasis is detrimental to neuronal activity and survival. 
Indeed, a close link between the pathogenesis of different neurodegenerative disorders and Ca2+ 
regulating systems, the so called “calcium hypothesis of neurodegenerative diseases”, has been 
convincingly forwarded by several experimental findings46,47. 
Different cellular perturbations as oxidative stress, perturbed energy metabolisms and aggregation 
of disease-related proteins can affect Ca2+ homeostasis. Dysfunctions of Ca2+-regulating proteins in 
PM, ER and mitochondria are involved in age-related neuronal diseases. The effects of aging on 
neuronal Ca2+ concentrations can be genetic or due to environmental factors that increase the risk of 
neurodegenerative disorders46. For example, age-related accumulation of ROS and perturbed 
cellular metabolisms, such as reduced mitochondrial functions, result in aberrant Ca2+ metabolism 
in different cell compartments, and are strictly associated with normal aging in most tissues, and 
also implicated in major neurodegenerative disorders48,49. 
Mitochondria are the major source of ATP, but also of ROS, in neurons. Therefore, alterations of 
Ca2+-dependent mitochondrial functions play a pivotal role in neuronal damage during aging or 
disease, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) 
and ALS47. Accordingly, analysis of brain tissues have shown alterations of Ca2+ homeostasis 
during the progression of different neurodegenerative disorders. For example, the AD-related 
amyloid beta (Aβ) peptide disrupts neuronal Ca2+ homeostasis, possibly via ROS production. This 
peptide (directly – by forming Ca2+-permeable pores in the PM – or indirectly) is also involved in 
the elevation of basal intracellular Ca2+ levels, which sensitize neurons to excitotoxicity and 
apoptosis46,49. 
Also in Amyotrophic Lateral Sclerosis there are many evidences of the correlation between protein 
misfolding and Ca2+ homeostasis. In fact recent research has found that mSOD1 alters Ca2+ 
homeostasis in MNs, and renders MNs particularly vulnerable to the activation of a subset of 
harmful pathways50,51. This could be the case, for example, of cytotoxic Ca2+ overloads, in light of 
the finding that fALS MNs exhibit abnormal Ca2+ levels in the cytosol and other cell 
compartments52–55. On the other hand, can also be assumed that ER and mitochondrial Ca2+ 
mishandling generates ER stress and mitochondrial dysfunctions, which have been causally linked 
to the disease. In addition, it has been recently provided evidence that the inherent excitability of 
MNs can act as an early endogenous neuroprotective mediator in mouse models of mSOD1 fALS, 
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suggesting that reduced excitability may be causally linked to the early progression of disease, in 
particular in the ALS-vulnerable “fast-fatigable” (FF) MN subset56. Given that Ca2+ is closely 
linked to neuronal excitability, it is likely that mutant SOD1-induced derangements of MN Ca2+ 
control are involved in the loss, or weakening, of neuroprotective pathways.  
Within the tenets of the Ca2+ hypothesis of neurodegenerative diseases, deregulation of Ca2+ 
signalling is one of the early events and key processes in disease pathogenesis. Of consequence, 
different approaches have been applied to protect or restore normal Ca2+ homeostasis in neurons, in 
order to prevent or delay Ca2+ overload and neuronal degeneration in acute and chronic 
neurodegenerative conditions57,58. Examples are drugs that suppress Ca2+ influxes, which – 
unfortunately – have the adverse effect to compromise normal neuronal functions in long-term 
treatment46.  
In summary, a better understanding of how derangements of Ca2+ fluxes promote neuronal demise 
in aging and neurodegenerative disorder may help identifying novel targets and strategies for 
neuroprotective therapeutic interventions49.  
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1.4 Astrocyte-MN cross-talk and its relevance to ALS 
The precise molecular mechanism(s) that target MNs to death in ALS still remain elusive, nor there 
are effective therapies that prevent or slow down disease progression. For this reason, a better 
understanding of ALS pathogenic mechanisms is very important to ameliorate the disease onset and 
progression.  
The long-standing view that MNs were the sole target of ALS and that MN damage occurred 
through cell autonomous pathways has been recently questioned by the idea that other cell types, 
such as glial cells and skeletal myocytes, contribute by in-trans (non-cell autonomous) mechanisms 
to MN demise. In addition, it is now largely accepted that astrocytes have both structural and 
functional interactions with neighbouring neurons, and are actively involved in synaptic 
transmission, forwarding the concept of “tripartite synapse” that involves pre-and post-synaptic 
neuronal terminals and adjacent astrocytes (Fig.5)59.  
 
Fig. 5 Structural and functional relationships of neurons and astrocytes and tripartite synapses. Scheme of one axon establishing a 
synapse on an apical dendrite of a prototypical pyramidal neuron and an astrocyte located close to it (in red). The large dashed circle 
illustrates an enlarged schematic view of the tripartite synapse, where the pre- and postsynaptic neuronal elements (in blue) are 
surrounded by astrocytic processes (in red). It also depicts the transfer of information between neuronal synaptic elements and 
astrocytic processes. Astrocytes respond with Ca2+ elevations to neurotransmitters (blue dots) released during synaptic activity and, 
in turn, control neuronal excitability and synaptic transmission through the Ca2+ -dependent release of gliotransmitters (red dots)59. 
Unlike neurons, astrocytes are not “electrically” active, but, nevertheless, they display “excitable” 
responses based on rapid and transient variations of the intracellular Ca2+ content. Such Ca2+ 
oscillations are key to regulate a broad variety of astrocytic functions, including the release of 
gliotransmitters that are relevant for astrocyte-to-neuron communication. Accordingly, altered 
astrocyte signalling has been suggested to contribute – through non-cell autonomous processes – to 
neuronal dysfunctions in different neurodegenerative disorders, including ALS38,60. For example, 
the silencing of mSOD1 expression in astrocytes slows disease progression in fALS Tg mice in 
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vivo60, while the specific expression of mSOD1 and mTDP-43 in astrocytes disrupts MN 
mitochondrial functions in primary astrocyte/MN co-culture models36.  
Furthermore, one of the major pathological feature of ALS is the activation and migration of 
astrocytes within and around the damaged regions of the spinal cord. This proliferation and 
adoption of a reactive phenotype is due to the response of astrocytes to cellular stresses61. During 
this neuroinflammation process, astrocytes become neurotoxic by losing their normal support and 
trophic function towards MNs, and secreting cytotoxic cytokines62. 
Another important aspect is that in normal conditions astrocytes are involved in the clearance of 
glutamate from the synaptic cleft to prevent neuronal excitoxicity due to glutamate overexposure. In 
ALS, however the expression of the excitatory amino acid transporter 2 (EAAT2), the major 
mechanism for glutamate uptake in astrocytes, is significantly decreased, resulting in MN 
excitotoxicity, both in the spinal cord of ALS patients63, and in animal models64.  
Astrocytes are also able to release factors selectively toxic to MN65,66, playing a role in the specific 
degeneration of spinal MNs in ALS. Important is also the finding implicating Ca2+ dysomeostasis of 
hSOD1(G93A)-expressing astrocytes (with release of neurotoxic factors) in MN degeneration66–68. 
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1.5 Genetically encoded Ca2+ indicators 
Ca2+ imaging is an increasingly used technical approach in cell biology to map intracellular Ca2+ 
signalling by measuring time- and space-resolved fluctuations of the ion concentration. This 
approach takes advantage of both chemical probes and genetically encoded Ca2+ indicators (GECI). 
The latter ones are fluorescent or luminescent Ca2+-sensitive proteins that are not toxic to cells and 
can be genetically targeted – by fusion to suitable signal peptide sequences – to specific cell 
organelles/compartments. Such probes can be efficiently transduced into living cells using different 
expression systems. 
Aequorin (AEQ) is a calcium-binding bio-luminescent protein produced by the jellyfish Aequorea 
victoria. This protein was isolated and characterized in the early sixties of the last century by 
Osamu Shimomura and colleagues69, but the first attempts to detect Ca2+ fluxes by AEQ date to the 
early seventies70. Thanks to the engineering of chimeric constructs containing specific targeting 
sequences, this photo-protein virtually allows the analysis of Ca2+ concentrations and dynamics in 
all cell compartments, including cytosol, cytosolic domains proximal to the PM, mitochondrial 
matrix and ER lumen. The advantages of using this kind of probe include the selective intracellular 
distribution, low background (and – consequently – high signal-to-noise ratio)and the possibility to 
introduce mutations in the Ca2+-sites for providing a wide dynamic range of Kd for Ca
2+ 
binding71,72. Given the low luminescent AEQ signal that requires cell population measurements, 
disadvantages of such a probe are principally related to the difficulty of obtaining sufficiently high 
rate of transduction in some cell preparations. This problem can be circumvented by use of 
(lenti)viral expression vectors73.  
AEQ is composed by an apoprotein (apoAEQ) with an approximate molecular weight of 21 kDa, 
and the prosthetic group coelenterazine (luciferin). apoAEQ contains three Ca2+-binding EF hand 
motifs that, upon cooperative Ca2+ binding, impart conformational changes promoting oxidative 
conversion of coelenterazine to coelenteramide and concomitant emission of light (λ =  469 nm) 73 
(Fig. 6). 
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Fig. 6 AEQ contains three Ca2+-binding domains. When non-covalently bound to its prosthetic group coelenterazine, AEQ binds to 
three Ca2+ ions catalysing the oxidation of coelenterazine into coelenteramide. The reaction is accompanied by emission of blue light 
(λ =  469 nm). 
Cameleon probes are based on fluorescence (or Förster) resonance energy transfer (FRET), a well-
known quantum mechanical process consisting in the non-radiating energy transfer from an exited 
fluorescent donor to an acceptor fluorophore placed in close proximity. Therefore, when FRET 
occurs, an increased fluorescence of the acceptor, together with a decreased fluorescence of the 
donor can be observed, and quantified as the ratio between the two fluorescent signals. To date, the 
most used GFP-modified proteins in cameleons are the cyan fluorescent protein (CFP, acting as 
donor) and the yellow fluorescent protein (YFP, acceptor) (Fig. 7).  
 
Fig. 7 In cameleons the donor and the acceptor are both derived from the green fluorescent protein (GFP, isolated from Aequorea 
victoria), and are separated – in a chimeric construct – by a Ca2+-sensing peptide consisting of calmodulin (CaM) and a CaM-binding 
peptide derived from the myosin light chain kinase M13 (M13), separated by a glycyl-glycine linker. While in the absence of Ca2+ 
(or the presence of low Ca2+ concentrations) the CaM/M13 domain presents in an extended form, when this Ca2+-sensing domain 
binds Ca2+ ions it forms a packed globular structure that brings the FRET donor and acceptor in close spatial proximity, thereby 
allowing FRET to occur. 
In last years, site-directed mutagenesis provided researcher with improved cameleon probes that 
possess increased brightness of the FRET acceptor, reduced competitive binding to endogenous 
CaM, and larger Kd range for Ca
2+ binding rendering such probes suitable for Ca2+ measurements in 
different cell districts, and under different conditions (e.g., basal Ca2+ levels, or Ca2+ transients upon 
cell stimulation)74,75. 
Transduction of genetic materials into target cells using viral infection often represents the unique 
solution with primary cultures. A number of different viral expression systems have been 
developed, including lentivirus-, adenovirus- and adeno-associated virus-based vectors. Each of this 
viral vectors has different characteristics and is suitable for different cell models and experimental 
settings (vigenebio.com). 
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In particular, in our project adeno-associated virus are used for cameleon probes while aequorin 
photo-protein is expressed in primary spinal astrocytes using lentiviral strategy.  
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Introductory Note 
 
My PhD activity was focused on two major projects, both relating to the involvement of Ca2+ 
dysmetabolism in ALS pathogenesis. The first one was aimed at generating and validating novel 
adeno-associated viral vectors for the selective expression in motor neurons of gene-encoded Ca2+ 
probes targeted to different cell compartments, thereby allowing in vitro and in vivo measurements 
of local Ca2+ homeostasis in cells that are the primary target of ALS injury. The second project 
aimed at identifying local perturbations of Ca2+ homeostasis in primary spinal astrocytes, derived 
from a well-characterised genetic murine model of ALS, as a possible mechanism of pathogenesis. 
The two parts of the thesis are presented in the format of scientific papers, such as they were 
presented for peer reviewing. The first part of the work is indeed ready to be submitted for revision 
to Scientific Reports, while the second part is a work in progress.  
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4.1 Abstract 
A finely tuned Ca2+ homeostasis in restricted cell domains is of fundamental importance for 
neurons, in which transient Ca2+ oscillations direct the proper coordination of electro-chemical 
signals and overall neuronal metabolism. Once such a precise regulation is unbalanced, however, 
neuronal functions and viability are severely compromised. Accordingly, disturbed Ca2+ 
metabolism has often been claimed as a major contributor to different neurodegenerative disorders, 
such as amyotrophic lateral sclerosis that is characterised by the selective damage of motor neurons 
(MNs). This notion highlights the need for probes allowing the specific and precise analysis of local 
Ca2+ dynamics in MNs. In this work, we generated and functionally validated adeno-associated 
viral vectors for the expression of genetically-encoded fluorescent Ca2+ indicators targeted to 
different cell domains under the transcriptional control of a MN-specific promoter. We 
demonstrated that the probes are specifically expressed, and allow reliable local Ca2+ 
measurements, in MNs from murine primary spinal cord cultures, and can also be expressed in vivo 
in spinal cord MNs upon systemic administration to newborn mice. Preliminary analyses have 
shown larger Ca2+ responses following stimulation of AMPA-sensitive ionotropic glutamate 
receptors in the cytosol of MNs from a murine genetic model of ALS compared to the healthy 
counterpart. 
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4.2 Introduction 
Ca2+ ions play a fundamental role in all cell types by controlling an impressive number of signalling 
events. Therefore, a precise control of Ca2+ homeostasis in the cytosol and other cell 
compartments/organelles – performed by several systems like pumps, channels, transporters and 
Ca2+-buffering proteins – is essential for cell physiology. In neurons, local Ca2+ fluctuations have a 
key physiologic impact, by controlling the spatiotemporal pattern of electrochemical signals, neurite 
outgrowth, synaptic plasticity and the patterning of dendritic spines (major factors in the 
neurochemical/neuroanatomical establishment of learning and memory), and, last but not the least, 
cell survival. Not surprisingly, small changes in Ca2+ dynamics can lead to pathological conditions1, 
and derangements of Ca2+ homeostasis has been frequently indicated as a major contributor to the 
onset of various neurodegenerative disorders, such as Alzheimer’s, Parkinson’s, and Huntington’s 
disease2. 
Among neurons, MNs are particularly sensitive to noxious cell Ca2+ overloads because they possess 
low levels of Ca2+-buffering proteins3,4. Also, they express high levels of Ca2+-permeable α-amino-
5-methyl-3- hydroxisoxazolone-4-propionate (AMPA) receptors that lack the GluR2 subunit, which 
makes them more vulnerable to dysregulation of intracellular Ca2+ homeostasis and excitotoxicity5. 
Not surprisingly, perturbed Ca2+ homeostasis has been claimed as a major actor in the pathogenesis 
of different MN disorders, such as amyotrophic lateral sclerosis (ALS) 6,7and spinal muscular 
atrophy 8. The above notions highlight the need for molecular tools, such as suitable Ca2+ indicators, 
for the specific and precise analysis of Ca2+ movements in different sub-cellular compartments of 
MNs. 
Historically, cell Ca2+ imaging has been developed in two different ways: the improvement of Ca2+ 
indicators and, in parallel, the progress of appropriate and sophisticated instrumentations (like 
confocal or multi-photon microscopy) to reach the capability of studying Ca2+mobility in vitro and 
in vivo. There are two major classes of Ca2+ indicators: chemical probes and genetically encoded 
calcium indicators (GECI). The first ones are hybridizations of small Ca2+-chelating molecules and 
a fluorophore. This class of probes include fura-2, quin-2, indo-1 and fluo-3, which are the first kind 
of indicators used for Ca2+ measurements in cells9. A second class of probes is that of GECI, which 
includes different types of engineered proteins such as green fluorescent protein (GFP)-derived 
fluorescent probes (e.g., GCamp), bioluminescent probes (e.g., aequorin) and fluorescence (or 
Förster) resonance energy transfer (FRET)-based indicators (e.g., cameleons). A clear advantage of 
these probes is that – at difference from chemical indicators – they can be genetically targeted to 
different cell domains/compartments for local Ca2+ measurements. On the other hand, they suffer 
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from the difficulty to be efficiently expressed in cells, in particular in primary neurons, which can 
be now easily overcome by use of viral expression vectors10–12. 
Cameleon probes are based on FRET, a well-known quantum mechanical process consisting in the 
energy transfer from an exited fluorescent donor to an acceptor fluorophore placed in close 
proximity. Therefore, when FRET occurs, an increased fluorescence of the acceptor, together with a 
decreased fluorescence of the donor can be observed and quantified. In last years, several studies 
based on site-directed mutagenesis have led to the generation of improved cameleon Ca2+ probes, 
by increasing the brightness of the FRET acceptor in response to Ca2+ fluctuations, reducing the 
possible competitive effect of endogenous CaM, and extending the affinity of cameleons for Ca2+ to 
render the probes suitable for Ca2+ measurements in different cell districts. In particular, different 
kinds of cameleon exist (classified as D1, D2, D3 and D413) covering a wide Kd range for Ca
2+ that 
allow scientists to choose the best probe for the specific cell compartment under study13–15. 
In this work, we have generated and functionally validated adeno-associated viral (AAV)-based 
vectors for the expression of cameleons targeted to different cell domains (i.e., cytosol, 
mitochondrial matrix, or endoplasmic reticulum (ER) lumen) under the transcriptional control of a 
MN-specific promoter. We demonstrate that such probes are specifically expressed in MNs (and not 
in other cell types) in primary cell cultures from the mouse spinal cord, and that they allow reliable 
Ca2+ measurements in the target cell compartment. Pilot experiments also demonstrate altered Ca2+ 
homeostasis in the cytosol of primary MNs from a genetic model of ALS, and that the generated 
AAV expression vectors can be suited for the in vivo expression of cameleons in spinal cord MNs 
in mice. 
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4.3 Results 
Given the plausible implication of perturbed Ca2+ homeostasis in the pathogenesis of MN 6–8 in this 
study we sought to generate and validate expression systems for GECI that were suited for the 
assessment of local Ca2+ fluctuations in MNs. To this purpose, we have engineered adeno-
associated virus (AAV) plasmids (pAAV) for the expression of cameleon probes targeted to the 
cytosol (pAAV-[Hb9_AB]-D1cpv), the mitochondrial matrix (pAAV-[Hb9_AB]-4mtD3cpv) and 
the ER lumen (pAAV-[Hb9_AB]-D4ER), under the control of a motor neuron-specific, homeobox 
Hb9-derived, promoter (Fig. S1, Supplementary online material). 
To validate such vectors for the specific recording of Ca2+ fluxes in MNs, we firstly checked the 
expression of our AAV-driven probes in the immortalised NSC-34 cell line that – when properly 
differentiated – displays several typical properties of motor neurons16,17 including the transcriptional 
activation of the Hb9 gene18. We therefore checked the expression of the three cameleon probes in 
NSC-34 cells, transduced with the AAV vectors, either cultured under proliferating conditions or 
induced to differentiate by treatment with retinoic acid (7 days, Fig. S2, Supplementary online 
material). We observed that all cameleons were abundantly expressed in differentiated cells but not 
in cells under active proliferation, suggesting that the Ca2+ probes were specifically expressed in 
cells resembling a MN phenotype (Fig 1). 
We then analysed by confocal microscopy the expression of cameleons in primary cultures from the 
spinal cord of mice expressing human superoxide dismutase 1 (hSOD1), either wild-type (WT) or 
bearing the ALS-related mutation (G93A). After 12 days of growth, such cultures contain different 
cell types, including mature MNs resembling their counterparts in intact spinal cord, both 
morphologically and for the expression of specific biological markers, such as the neurofilament 
protein SMI32. As described in Fig. 2, showing cultures from hSOD1(WT) mice, after transduction 
of such cell cultures with the AAV vectors, the cameleons (green signal, panels A,E,I) were 
expressed only in SMI32-positive cells (red signal, panels B,F,J) but not in other cell types 
(highlighted by nuclear staining, blue signal, panels C,G,K), providing evidence that the Hb9 
promoter-driven expression of the Ca2+ probes is specific for MNs (merge, panels D,H,L). 
The above conclusion is further reinforced by the finding that the AAV vectors are unable to drive 
the expression of the mitochondria-targeted cameleon in (almost pure) primary cultures of cortical 
(Fig. S3, Supplementary online material, panels A,B), hippocampal (panels C,D) or cerebellar 
granule (panels E,F) neurons, or spinal astrocytes (panels G,H). 
Next we checked that the cameleon had the expected sub-cellular14,19,20 distribution in primary 
MNs. As shown in Fig. 3, each probe (green signal, panels A,D,G) co-localised (yellow signal, 
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merged images of panels C,F,I) with immuno-labelled markers of the corresponding target 
compartment, i.e., HSP90 for the cytosol (panel B), Tom20 for mitochondria (panel E), and 
calreticulin for the ER lumen (panel H), indicating that the probes are correctly processed and 
delivered to the target site in AAV transduced MNs. 
ALS is a fatal neurodegenerative disorder that occurs on sporadic or genetic grounds, leading to a 
selective and progressive loss of MNs in the spinal cord, brainstem and cerebral cortex, thereby 
resulting in severe motor deficits and – eventually – to death 21,22. Since perturbations of Ca2+ 
homeostasis in MNs have been often claimed as a crucial event in disease progression7,23 we tested 
the applicability of the novel Ca2+-probe encoding vectors to the comparative analysis of local Ca2+ 
homeostasis in MNs from the hSOD1(G93A) ALS mouse model and the healthy hSOD1(WT) 
counterpart (the hSOD1 expression level being the same for both the genotypes). The cameleon 
probes of choice have great ratiometric sensitivity and large dynamic range, thereby allowing to 
detect small changes in Ca2+ concentration over the noise in the target compartment 13. In this work 
we did not calculated absolute Ca2+ concentrations that could be determined by suitable calibration 
procedures13, but simply reported the ratio between the acceptor and the donor fluorescence of the 
FRET-based probes, which – however – is sufficient for comparative analyses. Nonetheless, such 
experiments demonstrated that all cameleon probes were functional, and indicated that 
hSOD1(G93A)-expressing MNs have larger cytosolic Ca2+ transients following AMPA stimulation, 
compared to SOD1(WT) MNs (Fig 4A,B). Conversely, no significant difference was observed in 
AMPA-stimulated Ca2+ fluxes in the mitochondrial matrix (Fig. 4C,D). Also the ER-targeted 
cameleon was properly functioning, allowing the measurement of ER Ca2+ discharge upon 
stimulation with caffeine. Also in this case, no difference was observed between MNs with the two 
genotypes (Fig. 4E,F). 
Finally, we probed the use of the developed AAV-based expression systems for in vivo 
experiments. To this purpose, we injected the AAV vector coding for the mitochondrial or the ER 
cameleon into the superficial temporal vein of newborn hSOD1(WT) mice, and evaluated the 
expression efficiency of the probes in spinal cord sections 4 weeks later. By use of a fluorescence 
stereo-microscope, we observed an intense and diffuse signal in tissue samples of mice transduced 
with either the mitochondrial (Fig. 5A-C) or the ER (Fig. 5D-F) cameleon. Images collected at a 
higher magnification by a fluorescence microscope (Fig. 5G-I) showed that cells transduced with 
the ER probe had MN morphology, confirming the cell specificity of the expression system also in 
in vivo paradigms. 
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4.4 Discussion 
Recombinant AAVs are a powerful means for in vivo gene delivery24,25 and for the transduction of 
primary cell cultures that are particularly hard to transfect, such as neurons26,27. AAVs display low 
cytotoxicity and immunogenicity, are safe for the operator, and are suitable for long term gene 
expression in non-dividing cells with relatively high gene delivery efficiency, depending on the cell 
type28. 
In this work, we have generated pAAV plasmids encoding cameleon Ca2+ probes, genetically 
targeted to different cell compartments, under the transcriptional control of a MN-specific promoter. 
Given that AAV vectors has limited cloning capacity (i.e., large plasmids can hardly be packaged 
into AAV viral particles), we have chosen a genetically engineered minimal promoter of the Hb9 
gene (Hb9_AB), which is only about 550 bp in length and has already been demonstrated to 
specifically drive the expression of a transgene into MNs, both in vitro and in vivo29. For the 
preparation of the viral particles, we have chosen the AAV9 serotype because of its broad tropism, 
including the capacity to target neurons28. We have demonstrated that the engineered AAV vectors 
are suitable for the specific expression of the cameleons targeted to the cytosol, the mitochondrial 
matrix and the ER lumen of MNs from spinal cord primary cultures of mice, and allows measuring 
Ca2+ responses to proper stimuli in such cellular districts. These vectors have several advantages 
with respect to other expression systems or the use of ubiquitous promoters. Indeed, they allow Ca2+ 
measurements in single primary MNs with no need for difficult and time-consuming MN 
purification steps. In addition, MN Ca2+ measurements can be performed in a more physiologic 
environment, containing glial cells and other neuronal types, compared to pure MN cultures. 
We did not estimate the rate of AAV-mediated infection of MNs. However, a substantial number of 
SMI32-positive cells contained the Ca2+ probes at an expression level that easily allowed single cell 
recordings of Ca2+ dynamics. The transduction efficiency under our experimental setting was much 
higher than that achieved by transfection with plasmidic vectors, with which cameleon-expressing 
MNs were rarely found in each preparation, also when using a constitutive and ubiquitous 
(cytomegalovirus) or the pan-neuronal human synapsin1 (hSyn) promoter (data not shown). 
Among GECI, the ratiometric cameleon probes have several advantages, including low risk of 
artifacts, high sensitivity, good dynamic range, and the possibility to provide absolute Ca2+ 
concentration values upon proper calibration procedures13. In addition, engineering of mutant 
cameleons have provided researcher with several cameleons displaying a wide range of Kds for 
Part 1 
 
28 
 
Ca2+, thereby allowing reliable measurements of basal Ca2+ levels and evoked Ca2+ movements 
depending on the target cell compartment, the cell type and the desired stimulation protocol14,19. 
For cytosolic Ca2+ measurements we have cloned into pAAV vectors the D1-based probe30, which, 
although it is probably not the best suited cameleon for reliable basal Ca2+ measurements, allowed 
us to measure cytosolic fluctuations of the ion in MNs following AMPA stimulation. 
Correct Ca2+ handling by mitochondria is essential for cell physiology. On the one hand, the fine 
regulation of mitochondrial Ca2+ levels controls the mitochondrial production of ATP, because 
different mitochondrial enzymes rely on local Ca2+ concentration for their activity. On the other 
hand, mitochondria are a major Ca2+-buffering system avoiding noxious cytosolic Ca2+ overloads. 
While it is assumed that resting mitochondrial Ca2+ concentration is in the order of 10-1 M, upon 
stimulation promoting Ca2+ entry from the extracellular space or its release from the ER, Ca2+ levels 
in the mitochondrial matrix may reach up to 102 M, depending on the cell type and the stimulus31. 
Therefore, we have selected the 4mtD3cpv cameleon that, for its Kd and dynamic range, has been 
proved useful for measuring mitochondrial Ca2+ dynamics13. 
Finally, for the measurements of Ca2+ homeostasis in the ER lumen, we have chosen the recently 
generated D4ER probe14 that have been proved useful for comparative Ca2+ measurements in an 
experimental setting of neurodegenerative disorders32. 
Notably, cameleons are mostly expressed in SMI32-positive -MNs, enriched in the anterior 
ventral horn of the spinal cord33,34,which are particularly vulnerable to (AMPA-mediated) 
excitotoxic challenge and ALS-related damage6,7. Thus, to prove the efficacy of the probes to 
monitor local Ca2+ fluctuations in MNs, we have compared the response of MNs from mice 
expressing the ALS-related hSOD1(G93A) mutant, or the hSOD(WT)-expressing counterpart, to 
selected stimuli. In particular, we investigated Ca2+ responses in the cytosol and mitochondria to 
AMPA stimulation because excitoxicity has been proposed to contribute crucially to MN injury in 
ALS, probably as a consequence of glutamate-triggered Ca2+ overload7,35. Both the cytosolic and 
mitochondrial probe allowed the assessment of AMPA-mediated cell Ca2+ response, and 
underscored a larger entry of the ion in the cytosol, but not in mitochondria, of ALS MNs compared 
to the healthy controls, thus supporting the idea that Ca2+ overload may be involved in ALS MN 
damage. Also the ER cameleon was properly functioning, and monitored the ER Ca2+ discharge 
promoted by caffeine36,37, with no difference being observed between the two SOD1 genotypes. 
To our knowledge, the novel vectors we generated in this work allowed for the first time to directly 
monitoring local Ca2+ fluctuations in subcellular compartments of primary mouse MNs, thereby 
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providing valuable and versatile tools for expanding our knowledge on Ca2+-related pathogenic 
routes in ALS and other neuromuscular diseases. With this respect, it is worth underlining that other 
GECI-encoding sequences can be easily cloned into the generated MN promoter-containing pAAV 
scaffold, thereby providing expression systems for Ca2+ probes with different properties (e.g., Kd) 
for appropriate Ca2+ measurements under different experimental protocols. 
Importantly, we provided evidence that the AAV vectors can also drive the in vivo expression of the 
Ca2+ probes. This result was achieved by systemic administration of the virus, which is by far less 
invasive and arduous than local injection in the spinal cord of live mice.  
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4.5 Materials and Methods 
4.5.1 Plasmid construction 
Multiple pAAV have been generated, for the expression of the FRET-based cameleon Ca2+ probes 
targeted to different cellular compartment (i.e. cytosol, mitochondrial matrix and ER lumen13,14,19,20 
under the control of either a minimal promoter (Hb9_AB) derived from the (MN)-specific promoter 
of the Hb9 gene29, or the pan-neuronal hSyn promoter. 
Starting from the pAAV-[hSyn]-ChR2/EYFP vector (Addgene, cat. # 26973) (Fig. S1, panel A), we 
inserted the sequence coding for the cytosolic probe (D1cpv), previously isolated by BamHI-EcoRI 
cleavage of a pcDNA3-D1cpv plasmid (kindly provided by Dr. Roger Tsien, University of 
California, San Diego, USA;13,19), at BamHI-EcoRI sites. After digestion, purified DNA fragments 
were ligated in vitro by T4 DNA ligase, and E. coli TOP10 cells were transformed to recover the 
pAAV-[hSyn]-D1cpv plasmid (Fig. S1, panel B). Similarly, at KpnI-HindIII sites of the pAAV-
[hSyn]-ChR2/EYFP vector we inserted the sequence coding for the ER lumen probe (D4ER), which 
was previously amplified by PCR using as template the pcDNA3- D4ER plasmid (kindly provided 
by Dr. Paola Pizzo, Dept. of Biomedical Science, Univ. of Padova) and the primers ER-K1-F and 
ER-H3-R (sequences reported in the Supplementary online material). The PCR product was 
digested with KpnI-HindIII, and purified DNA fragments ligated as indicated above, generating the 
pAAV-[hSyn]-D4ER plasmid (Fig. S1, panel B). 
Finally, we performed the substitution of the [hSyn] promoter sequence with the 550 bp motor 
neuron specific promoter [Hb9_AB], which was previously amplified by PCR using as template the 
Bg.Hb9_AB plasmid29 (kindly provided by Dr. Caterina Bendotti, IRCCS Istituto di Ricerche 
Farmacologiche Mario Negri, Milano, Italy), and primers AB-M1-F and AB-K1-R (sequences 
reported in the Supplementary online material). The PCR product, subjected to MluI-KpnI cleavage 
and purified, was then ligated to both pAAV-[hSyn]-D1cpv and pAAV-[hSyn]-D4ERcpv plasmidic 
fragments digested with the same enzymes that removed the hSyn promoter sequence. We also 
generated the pAAV-[Hb9_AB]-4mtD3cpv vector, expressing the probe targeted to the 
mitochondrial matrix (4mtD3cpv), by replacing the hSyn promoter of the pAAV-[hSyn]-4mtD3cpv 
plasmid (a generous gift by Dr. Paola Pizzo, Dept. of Biomedical Science, Univ. of Padova), with 
the Hb9_AB promoter. After transformation and selection of E. coli cells, some positive clones 
were isolated, recombinant plasmids were checked by specific DNA restriction, and finally 
validated by sequencing. All enzymes were from New England Biolabs, excepted the high-fidelity 
DNA polymerase (KAPA Biosystems), and DNA primers (Life Technologies). DNA manipulations 
have been performed accordingly to standard methods38 and to manufacturer’s instructions. 
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Detailed maps and plasmids sequences are all available upon request to the corresponding author. 
AAV viral particles (AAV9 serotype) were commercially produced by Vigene Biosciences with 
viral titer ranging from 2  1013 to 10  1013 GC/ml. 
4.5.2 Animals 
Tg mice expressing WT hSOD1 or the ALS-related G93A mutant of hSOD1 (B6SJL(Tg-
SOD1)2Gur/J and B6SJL(Tg-SOD1*G93A)1Gur/J mice, respectively) were purchased from The 
Jackson Laboratories. Since the transgenes contains the entire hSOD1 gene, including the 
endogenous SOD1 promoter39, the expression of both WT and mutant hSOD1 mimics the natural 
pattern of SOD1 expression. The colonies were maintained by breeding hemizygous (Tg) males to 
wild-type B6SJLF1/J hybrid females. Embryos and newborns were genotyped (as described in 
supplementary materials), and used for subsequent experiments. All aspects of animal care and 
experimentation were performed in compliance with European and Italian (D.L. 26/2014) laws 
concerning the care and use of laboratory animals. The authors’ Institution has been accredited for 
the use of experimental mice by the Italian Ministry of Health, and by the ethical committee of the 
University of Padova (Organismo Preposto al Benessere degli Animali, OPBA). 
For mouse genotyping and NSC34 cell culturing, see Supplementary Online Material. 
4.5.3 Primary cultures 
Primary spinal cord cell cultures (containing MNs and other cell types) were established from E12.5 
mouse embryos according to Henderson’s protocol (Mettling et al. 1995)40. Briefly, spinal cords 
were dissected from individual embryos in Hybernate medium (Gibco) added with 2% (v/v) B27 
supplement (Gibco), and tissue was cut (< 1 mm pieces) and incubated (8 min, 37 °C) in a buffer 
containing NaCl (124 mM), KCl (5.4 mM), NaH2PO4 (1 mM), glucose (3.6 mM), HEPES (25 mM, 
pH 7.4), added with BSA [0.3% (w/v)] and trypsin [0.025% (w/v)]. 
Then, cells were gently dissociated in a buffer made of Leibovitz’s medium (L15, Gibco) 
supplemented with sodium bicarbonate [7.5% (w/v)], horse serum [HS, 2% (v/v)], glucose [7.2% 
(w/v)], progesterone [0.1% (w/v)], insulin [1% (w/v)] , putrescine [1% (w/v)], conalbumin [1% 
(w/v)], sodium selenite [0.1% (w/v)] , BSA [0.4% (w/v)] and DNase I [0.1 mg/ml]. 
The cell suspension was then centrifuged (500 x g, 5 min, RT) over a cushion of BSA [4% (w/v)] 
(in the above medium), after which cells were recovered from the bottom of the tube, resuspended 
in a MN culture medium consisting of Neurobasal medium (Gibco) supplemented with HS [2% 
(v/v)], B27 [2% (v/v)], L-glutamine [0.05 mM], glutamate [25 µM], mercaptoethanol [25 µM], 
BDNF [10 ng/ml], GDNF [10 ng/ml], and CNTF [10 ng/ml], penicillin [100 U/ml], streptomycin 
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[100 µg/ml].  Cells were then plated at a density of approximately 500.000 cells/well in 12-wells 
culture plates containing (18 mm diameter) glass coverslips coated with poly-D-ornithine (1.5 
µg/ml in sterilized bidistilled H2O, 2 h, RT) and then with laminin (3 µg/ml in L15 medium, 3 h, 37 
°C in a 5% CO2 atmosphere), and grown (37 °C in a 5% CO2 atmosphere). 
Primary cultures of CGN and cortical neurons were prepared as described in De Mario et al. 
(2015)41. Hippocampal neurons were prepared following the same procedures for cortical neurons, 
except that they were grown in Neurobasal medium added with FBS [10% (v/v)]. 
Primary cultures of spinal astrocytes were isolated from newborn mice and cultured as described 
previously in Martorana et al. (2012)42. Once the cultures reached the confluence, they were re-
plated at the optimal density 80.000 cells/well in 24-well plates containing glass coverslips and 
maintained in minimal essential medium (MEM, Gibco), supplemented with FBS [10% (v/v)], L-
glutamine [2 mM], glucose in phosphate buffered saline [PBS, 0.3% (w/v)], penicillin [100 U/ml], 
streptomycin [100 µg/ml]. 
On day 2 from plating, all primary cultures were transduced with the AAV9-Hb9-cyt or AAV9-
Hb9-mt or AAV9-Hb9-ER (0.5 μl of viral suspension containing 3×1010 GC/ml) and used in 
experiments at different times depending on the cell type. 
4.5.4 Immunocytochemistry 
For immunocytochemical analysis, cells were firstly washed in ice-cold PBS, and fixed (20 min, 
RT) in paraformaldehyde [PFA, 4% (w/v)] in PBS. After washing in PBS, cells were permeabilized 
in PBS containing Triton X-100 [1 h, RT, 0.02% (w/v)] and then incubated (overnight, 4 °C) with 
the following primary antibodies [Ab diluted in 1% (w/v) BSA, in PBS]: anti-SMI32 mouse 
monoclonal (m) Ab (1:200, Covance, cat. n. SMI-32R & SMI-32P); anti-glial fibrillary acidic 
protein (GFAP) rabbit polyclonal (p) Ab (1:500, Dako, cat. n. Z0334); anti-microtubule-associated 
protein-2 (MAP-2) chicken pAb (1:1000, Abcam, cat. n. ab5392); anti-calreticulin rabbit pAb (1:50, 
Stressgen, cat. n. ADI-SPA-600-J); anti-Hsp90 mouse mAb (1:100, BioScience, cat. n. 610418BD); 
anti-Tom20 rabbit pAb (1:50, Santa Cruz Biotechnologies, cat. n. sc-11415). After extensive 
washings in PBS, cells were incubated (1 h, 37 °C) with the following secondary antibodies, 
depending on the used primary Ab: Alexa Fluor 555-conjugated anti-mouse IgG (1:500, Molecular 
Probes); rhodamine-conjugated anti-rabbit IgG (1:100, Dako); Alexa Fluor 568-conjugated anti-
chicken IgG (1:500, Molecular Probes). Cell nuclei were counter-stained with Hoechst 33342 (5 
μg/ml, Sigma), and coverslips were finally washed in PBS, mounted in montage solution [8% 
Mowiol 40-88 (Sigma) in glycerol and PBS (1:3 (v/v)], and observed with an inverted fluorescence 
microscope (Leica CTR6000) equipped with a computer-assisted charge-coupled camera (Orca 
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Flash 4.0, Hamamatsu), or with a confocal microscope system (Leica TCS-SP5), which also 
allowed the acquisition and analysis of digital images. 
4.5.5 Ca2+ imaging 
For Ca2+ imaging, 12 days after plating, cells were mounted into an open-topped chamber and 
maintained under perfusion with a modified Krebs-ringer buffer (NaCl 125 mM, KCl 5 mM, 
KH2PO4 0.4 mM, MgSO4 1 mM, glucose 5.5 mM, HEPES 20 mM, pH 7.4) containing CaCl2 (2 
mM) (KRB), through a temperature-controlled (37 °C) instrument (TC-324B, Warner Instruments,). 
Cells were stimulated with AMPA (Tocris, 25 M) for cytosolic and mitochondrial Ca2+ 
measurements, or with 100 M caffeine for ER Ca2+ measurements (both stimuli carried out in 
KRB). 
Cell were analysed using a DM6000 inverted microscope (Leica) with a 40X oil objective (HCX 
Plan Apo, NA 1.25). Excitation light produced by a 410nm led (LZ1-00UA00-LED, Led Engin) 
was filtered at the appropriate wavelength (425 nm) through a band-pass filter, and the emitted light 
was collected through a dichroic mirror (515 DCXR, Chroma Technologie), and a beam-splitter 
(OES) with emission filters (Chroma Technologies) HQ 480/40M (for CFP) and HQ 535/30M (for 
YFP). The beam-splitter permits the collection of the two emitted wavelengths at the same time, 
thus preventing any artefact due to uncontrolled movement of the recording chamber and/or 
intracellular organelles. Images were acquired using an IM 1.4C cooled CCD (Jenoptik Optical 
Systems) attached to a 12-bit frame grabber. Synchronization of the excitation source and the CCD 
was performed through a control unit ran by a custom-made software package (developed by C. 
Ciubotaru, Venetian Institute of Molecular Medicine, Padova, Italy), which was also used for image 
acquisition, with an exposure time of 100 ms and a time-shift of 0.5 s. The software allows with-
time recordings of the ratio between the acceptor and the donor fluorescence intensity (R) (sampling 
rate = 1 s-1) that is taken as a relative measurement of Ca2+ concentration. 
4.5.6 In vivo AAV-mediated delivery of cameleons  
For in vivo delivery of AAV vectors, we have used P1 hSOD1 WT mice, in light of previous reports 
demonstrating much higher transduction rates in newborns than in adult mice43,44. After anaesthesia 
by topical administration of lidocaine, neonatal hSOD1(WT)-expressing mice (P1) received 50 μl 
of viral suspension containing 3×1011 GC/ml of AAV9-Hb9-mt, AAV9-Hb9-ER, or vehicle (PBS), 
into the temporal vein using a Hamilton syringe with a 32-gauge needle. The injections were 
performed in laboratory Biosafety Level 2 (BL2). 
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Four weeks after the injection, animals were anesthetized by CO2 before killing by cervical 
dislocation, and spinal cords were collected and successively fixed in PFA [24 h, 4◦C, 4% (w/v)]. 
Post-fixed tissues were transferred to sucrose [30% (w/v)] in PBS (overnight, 4◦C) for 
cryoprotection. 20 μm-thick sections were serially cut on a cryostat (Leica Microsystems), nuclei 
were counter-stained with Hoechst 33342 (see immunocytochemistry), mounted in montage 
solution on a glass coverslip, and observed with a fluorescence stereo-microscope (Leica M205-
FA), or with an inverted fluorescence microscope (Leica CTR6000) equipped with a computer-
assisted charge-coupled camera (Orca Flash 4.0, Hamamatsu). 
4.5.7 Statistical analysis 
Off-line analysis of FRET data was performed with the ImageJ software. YFP and CFP images 
were subtracted for the respective background signals, and distinctly analysed after choosing proper 
regions of interest (ROI) on selected cells. Subsequently, the ratio between YFP and CFP emission 
fluorescence intensity (F) was calculated (R = F535/F480) and reported as %. All the data are 
representative of at least n (indicated in the figures and/or figure legends) independent experiments, 
and are reported as mean ± standard error of the mean (SEM). Statistics were performed by 
unpaired Student’s t test, with a p value < 0.05 being considered statistically significant. 
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4.7 Legends to Figures 
Figure 1. The cameleon probes under the control of the Hb9-derived promoter are expressed 
in differentiated, but not in non-differentiated, NSC-34 MN cells. NSC-34 cells were infected 
with the AAV vectors coding for the Hb9_AB-driven cameleon probes targeted to the cytosol 
(D1cpv, panels A-D), the mitochondrial matrix (4mtD3cpv, panels E-H), or the ER lumen (D4ER, 
panels I-L), and then cultured (7 days) under non-differentiating (proliferating, panels A,B,E,F,I,J) 
or differentiating (by growth in the presence of retinoic acid 5 M, panels C,D,G,H,K,L) 
conditions. Fluorescence (ex = 488 nm, em = 526/550 nm) and differential interference contrast 
(DIC) micrographs of representative fields were taken with a suitable microscope equipped with a 
CCD camera. No fluorescent cell was observed in non-differentiated NSC-34 cultures, while the 
fluorescent Ca2+ probes were expressed in cells differentiated towards a MN phenotype. Shown data 
are representative of at least 3 independent experiments yielding comparable results. Scale bar = 20 
µm. 
Figure 2. The cameleon probes are selectively expressed in motor neurons in mouse spinal 
cord primary cultures. Primary cell cultures from the spinal cord of Tg mice expressing 
hSOD1(WT) were transduced with the AAV vectors coding for the cameleons targeted to the 
cytosol (panels A-D), the mitochondrial matrix (panels E-H) or the ER lumen (panels I-L). After 12 
days of culturing, cells were fixed, permeabilised, immunostained with an antibody to the MN 
marker SMI32, and then counter-stained with the nuclear fluoro-probe Hoechst 33342. 
Confocal microscope images of cells were then collected after excitation at either  = 488 nm for 
visualising the fluorescent Ca2+ probes (green signal, panels A,E,I),  = 543 nm for visualising 
SMI32-positive cells (red signal, panels B,F,J), or  = 405 nm for visualising the nuclei of all cells 
(blue signal, panels C,G,K). Merging of the three fluorescent channels (panels D,H,L) shows that 
only SMI32-positive MNs express the Ca2+probes. Similar results were obtained using 
hSOD1(G93A)-expressing Tg mice (Data not shown). Scale bar = 20 µm. 
Figure 3. The cameleon probes correctly localize to the target sub-cellular compartment in 
primary MNs. Primary cell cultures from the mouse spinal cord were transduced with the AAV 
vectors coding for the cameleons targeted to the cytosol (panels A-C), the mitochondrial matrix 
(panels D,F) or the ER lumen (panels G-I). After 12 days of culturing, cells where fixed, 
permeabilised, and immunostained with antibodies to proteins present in the cytosol (Hsp-90, panel 
B), mitochondria (Tom-20, panel E), or the ER (calreticulin, panel H). Fluorescence images of cells 
were then collected by a confocal microscope after excitation at either  = 488 nm for visualising 
the fluorescent Ca2+ probes (green signal, panels A,D,G), or  = 543 nm for visualising the 
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immuno-labeled proteins (red signal, panels B,E,H). Merged images (panels C,F,I) show a 
remarkable overlapping of the green and red signals, demonstrating  the correct sub-cellular 
targeting of all used Ca2+ probes. Scale bar = 20 µm. 
Figure 4. Measurements of Ca2+ basal levels, and Ca2+ transients following stimulation, in 
different domains of primary spinal cord MNs. Primary spinal cord cultures from hSOD1(WT) 
or hSOD1(G93A) were transduced with the AAV vectors coding for the cameleon probes targeted 
to the cytosol (panels A,B), the mitochondrial matrix (panels C,D) or the ER lumen (panels E,F). 
After 12 days of culturing, FRET measurements were performed on single MNs expressing the 
different Ca2+ probes using a computer-assisted fluorescence microscope equipped with a suitable 
system for double-wavelength excitation. The ratio R) between the FRET acceptor and donor was 
calculated by the data acquisition software, allowing the comparison of Ca2+ mobilisation following 
stimulation with AMPA (25 M in the presence of 2 mM CaCl2, for the cytosol and the 
mitochondrial matrix) or caffeine (100 M, for the ER) at the time-points indicated by arrows, 
between hSOD1(WT) or hSOD1(G93A) MNs. Panels A,C,E report average traces of the Ca2+ 
dynamics (for seek of clarity error bars are not reported), while bar diagrams of panels B,D,F report 
the mean difference between FRET ratios (R = Rpeak - Rbaseline) following the indicated stimulus in 
the three cell compartments. While no difference was recorded in Ca2+ movements in the 
mitochondrial matrix or the ER lumen, the cameleon-based approach highlighted a significantly 
higher Ca2+ response following AMPA stimulation in the cytosol of hSOD1-G93A-expressing MNs 
compared to the hSOD1-WT counterpart. Data are reported as mean ± standard error of the mean 
(SEM); n = 6 (A and B), 12 (C and D), 9 (E and F); * p < 0.01, Student’s t-test. 
Figure 5. The MN promoter-driven cameleons can be efficiently and specifically expressed in 
MNs after in vivo transduction of mice with the AAV vectors. Neonatal (P1) hSOD1(WT)-
expressing Tg mice were injected into the temporal vein with AAV vectors encoding the 
mitochondrial (panels A-C) or the ER (panels D-I) cameleon. Mice were sacrificed 4 weeks after 
injection, and spinal cord cross-sections were stained with the nuclear fluorescent dye Hoechst 
33342 and observed with a fluorescence stereo-microscope (panels A-F) or an inverted fluorescence 
microscope (panels G-I). Low-resolution stereo-microscopy shows a diffuse expression of both 
fluorescent Ca2+ probes (green signal), indicating that the cameleons are effectively transduced and 
expressed in the spinal cord in vivo. The higher resolution provided by the fluorescence microscope 
shows that the signal of the ER cameleon is only present (to different extent) in cells resembling the 
morphology of large MNs (arrowheads in panel I), suggesting the cell-specific expression of the 
probe. Scale bars = 200 µm (A-C), 150 µm (D-F), 10 µm (G-I). 
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5.1 Abstract 
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterised by the 
selective damage and death of motor neurons (MNs), probably by a combination of cell- and non-
cell-autonomous processes. The past decades have brought many important insights into the role of 
astrocytes in normal nervous system function and disease, and there is evidence suggesting that they 
play a key part in MN demise in ALS. In addition, recent studies suggested a fundamental 
implication of perturbed Ca2+ homeostasis in the pathogenesis of this neurodegenerative disorder 
and, possibly, also in MN-astrocyte cross-talk in ALS. 
These observations prompted us to investigate Ca2+ homeostasis and the expression of major 
systems involved Ca2+ metabolism in different cells compartment of primary spinal astrocytes 
derived from the hSOD1(G93A) ALS mouse model in comparison with the hSOD1(WT)-
expressing controls. 
Following previous results from other groups, we found that store-operated Ca2+ entry – a cell Ca2+-
refilling mechanism responsive to endoplasmic reticulum (ER) Ca2+ depletion – is significantly 
enhanced in SOD1(G93A). We also observed that stimulation of purinergic receptors induces an 
excess of Ca2+ release from the ER stores in SOD1(G93A) astrocytes. We provide possible 
mechanistic explanation for these results. 
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5.2 Introduction  
ALS is an adult-onset MN disease that mainly develop on sporadic grounds, but can also be induced 
by autosomal mutations in different genes. Such mutations determine MN demise by both cell 
autonomous and non-cell-autonomous events. Important insights on the pathogenic mechanisms 
came from studies in mice expressing ALS-related mutant (m) forms of human (h) superoxide 
dismutase 1 (SOD1). This studies have shown that non-neuronal cells (e.g., glial cells and skeletal 
myocytes) may substantially contribute to mSOD1-associated MN damage by in-trans mechanisms. 
Following the seminal work by Cleveland and colleagues1–3, for example, many pieces of evidence 
have underscored that altered astrocytic signalling, including Ca2+ dysmetabolism, disrupts MN 
functions and viability in different ALS models4–9. 
In this context, it worth noting that astrocytes, the most abundant non-neuronal cells surrounding 
MNs, have a pivotal role in the maintenance of neuronal metabolism, by releasing neurotrophic 
factors and sequestering glutamate from the synaptic cleft, thereby protecting neurons from 
glutamate excitotoxicity. Several in vivo and in vitro studies revealed many pathogenic changes in 
ALS astrocytes, including disrupted Ca2+ homeostasis10, suggesting that altered astrocytic functions 
and/or release of different (neurotoxic) molecules by astrocytes concur to MN death11. Therefore, 
clarifying (Ca2+-dependent) ALS-associated alterations of the astrocyte-MN cross-talk may help 
understanding pathogenic pathways and devising novel therapeutic targets. 
To get insights into these issue, we studied possible alterations of local Ca2+ homeostasis in primary 
astrocytes from the murine SOD1(G93A) ALS model, following stimulation of store-operated Ca2+ 
entry (SOCE) or purinergic receptors by adenosine triphosphate (ATP). 
Thanks to the fact that primary astrocytes from spinal cord of newborn mice can be easily obtained 
with high purity and transduced with expression vectors, we were able to perform comparative 
analyses on astrocytes expressing the ALS-related hSOD1(G93A) mutant and the wild-type (WT) 
counterpart. In particular, for the analysis of Ca2+ transients we used aequorins (AEQs) that allowed 
measuring Ca2+ concentrations in different cellular compartments, thanks to suitable targeting 
sequences.  
In recent years SOCE has been proposed as an important mechanism of cell Ca2+ entry, 
distinguished from that mediated by canonical voltage- or ligand-gated channels. It has been 
described to occur upon intracellular Ca2+ store depletion that leads to the opening of store-operated 
Ca2+ channels (SOCCs), allowing external Ca2+ entry in the cells through the plasma membrane 
(PM) and replenishment of the endoplasmic reticulum (ER) Ca2+ stores. This “new” type of Ca2+ 
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channel was first described in non-neuronal cells (e.g., lymphocytes), but its importance is now 
becoming increasingly recognized also in neurons, whereby it could play a role in excitability.  
The first description of SOCE (also called capacitive Ca2+ entry) was forwarded by Bird et al. 
(1993)12, who reported that sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) inhibitors (e.g., 
thapsigargin) elicited Ca2+ entry from the extra-cellular space with no need of activating the typical 
cell surface channels. Only 20 years later, however, the molecular mechanisms of SOCE were 
eventually discovered thanks to the identification and cloning of two protein families: the ER 
stromal interaction molecules (STIM) (with STIM1 and STIM2 isoforms), and that of the PM 
ORAI proteins (with ORAI1-3 isoforms)13,14. 
Astrocytes exhibit elevated intracellular Ca2+ levels in response to SOCE activation, and some 
finding suggests an enhanced S-glutathionylation of STIM1 and aberrant SOCE and ER Ca2+ filling 
in mutant hSOD1(G93A) astrocytes15.  
In the second part of this work we analysed astrocytic Ca2+ fluxes following purinergic stimulation. 
Purinergic receptors are a family of PM proteins divided into two large families: ligand-gated ion 
channels (P2X ionotropic receptors) and G-protein coupled receptors (P1 and P2Y metabotropic 
receptors). The first ones are non-selective cation channels that mediate entering of Ca2+ ions from 
the extra-cellular space as a response to ATP stimulation. The second class of receptors can be 
distinguished on the basis of ligand recognition: P1 receptors are selectively activated by adenosine, 
while P2Y receptors are preferentially activated by ATP. Considering that one of the most 
important achievements in the field of purinergic transmission was the demonstration that in the 
brain intercellular communication is also mediated by ATP P2 receptor activation on astrocytes16, 
we hypothesize that this nucleotide-induced activation may act as a defence mechanism to protect 
neurons, but its dysregulation in disease can lead to chronic inflammatory processes and neuronal 
cell damage and death, such as those occurring in ALS.  
Our study has underlined altered Ca2+ homeostasis in different cellular compartments of spinal 
hSOD1(G93A) astrocytes after the above-described stimulation protocols, which is likely correlated 
to a different expression of some Ca2+-transporting systems. Our data thus confirm and extend 
previous experimental evidence reporting enhanced S-glutathionylation of STIM1 and aberrant 
SOCE and ER Ca2+ filling in hSOD1(G93A) astrocytes15. We also propose a novel mechanism for 
the specific role of P2 receptors in astrocytes (enhanced Ca2+ release from the ER upon ATP 
stimulation) that may provide the basis for neuroprotective strategies. 
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5.3 Results and Discussion 
5.3.1 hSOD1(G93A)-expressing astrocytes have enhanced SOCE-mediated Ca2+ influx 
Considering that astrocytes have a well-recognised pivotal role in the tripartite synapse and seems 
to be involved in ALS pathogenesis, and that the control of Ca2+ homeostasis is fundamental for the 
life and functions of astrocytes5,17, we decided to study Ca2+ dynamics in primary spinal astrocytes 
from hSOD1(G93A) and hSOD1(WT) mice. Starting from a recent work suggesting oxidative 
stress-induced S-glutathionylation and Ca2+-independent clustering of the ER Ca2+ sensor STIM115, 
which determine abnormal SOCE in hSOD1(G93A)-expressing murine astrocytes, we decided to 
perform an analysis of local Ca2+ homeostasis in these cells compared to the WT counterpart. 
Thanks to our tools, we were able to measure Ca2+ fluxes in different cell compartments, in order to 
define a more precise picture of Ca2+ dysmetabolism in ALS astrocytes. 
We explanted primary astrocytes from the spinal cord of newborn (P 0-1) hSOD1(G93A) and 
hSOD1(WT) mice and, after three weeks of culture, astrocytes were re-plated and analysed for 
different Ca2+-related parameters (Fig. 1). We obtained almost pure (>97%) cultures as determined 
by immunofluorescence analysis for the astrocytic marker glial fibrillary acidic protein (GFAP) 
(Fig. 2). Morphology did not significantly differ between the two hSOD1 genotypes astrocytes (data 
not shown). 
Intracellular Ca2+ dynamics, following SOCE stimulation, were evaluated by live-cell analysis 
using the bioluminescence photo-protein AEQ targeted to different cell compartments (i.e., 
cytosolic PM micro-domains (AEQpm), bulk cytosol (AEQcyt), ER lumen (AEQER) and 
mitochondrial matrix (AEQmit). To maximally activate SOCE, we firstly depleted intracellular Ca
2+ 
stores (by incubation in a Ca2+-free buffer containing EGTA 100 µM), and then perfused cells with 
1 mM CaCl2. 
Fig. 3 reports Ca2+ fluctuations in PM micro-domains (A) and in the cytosol (B), as detected by 
AEQpm and AEQcyt respectively. The rise of [Ca
2+]pm (Fig. 3A) and [Ca
2+]cyt (Fig. 3B) had a 
significantly higher (of 30% and 25%, respectively) peak value in hSOD1(G93A) (red) than in 
hSOD1(WT) (black) astrocytes, indicating that hSOD1(G93A) expression leads to higher SOCE-
mediated Ca2+ replenishment of astrocytes. These findings were confirmed by a higher Ca2+ uptake 
by the ER of hSOD1G93A astrocytes following SOCE activation (Fig.4). 
The mechanism of SOCE activation involves two families of ER resident and PM proteins, which 
are STIM1-2, and ORAI1-3, respectively18. In particular, STIM1 and 2 sense luminal Ca2+ changes 
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with different sensitivity. STIM1, whose EF-hand motif binds Ca2+ with low affinity (ideal to sense 
substantial changes of the luminal ER Ca2+ concentration), is uniformly distributed in the ER 
membrane at resting conditions, whereas it oligomerizes upon Ca2+ depletion in membrane punctae 
closely juxtaposed to the PM, thereby recruiting the PM channel-forming ORAI proteins, and 
promoting pore opening, possibly through protein-protein interaction14,19. Conversely, STIM2 is 
sensitive to mild reductions of ER Ca2+ concentration, so that STIM2 could form PM-recruiting 
punctae already at resting ER Ca2+ concentrations20,21.  
To determine whether enhanced SOCE in hSOD1(G93A) astrocytes was attributable to increased 
expression of the components of the SOCE molecular mechanism, we evaluated by Western blot  
(WB) the expression of STIM1, STIM2, ORAI1 and ORAI3 (ORAI2 is under analysis), but no 
significant difference was observed  (Fig. 5). Following the findings by Kawamata et al. (2014)15 
demonstrating that STIM1 S-glutathionylation is responsible for abnormal SOCE in hSOD1(G93A) 
primary spinal cord astrocytes, we confirmed the enhancement of total proteins S-glutathionylation 
in the same ALS cell paradigm (data not shown), supporting the contention that increased SOCE 
could be due to Ca2+-independent STIM1-containing puncta formation. 
The maintenance of proper intracellular Ca2+ concentrations is guaranteed by an efficient network of 
Ca2+-transporting pathways and by Ca2+-buffering proteins present in the cytosol and in the lumen 
of intracellular Ca2+-storing compartments22. The ER is generally believed to be the most important, 
metabolically relevant, reservoir and buffering compartment for cellular Ca2+. The ER lumen 
contains high Ca2+concentration and several Ca2+-binding proteins23,  and fluctuations of [Ca2+]ER 
may affect Ca2+-dependent processes both in the lumen of the organelle and in other cell 
compartments (e.g., changes in cytosolic and mitochondrial Ca2+ levels that might affect numerous 
signal transduction pathways)24. 
Considering that the mechanisms controlling Ca2+ storage in the ER are key to cell Ca2+ 
homeostasis, and that many severe diseases result from impaired function of the ER membrane or 
ER Ca2+ binding proteins, we analysed by WB the expression of Ca2+-binding proteins or Ca2+-
transporting systems. Although Ca2+-binding proteins such as calreticulin (CRT), calnexin (CLNX) 
and GRP78 did not show significant differences between the two hSOD1 genotypes (Fig.6A-C), we 
found that sarco-endoplasmic reticulum (SERCA, Fig.6D) and PM Ca2+ ATPases (PMCA, Fig. 6E) 
are overexpressed in hSOD1(G93A) astrocytes compared to the hSOD1(WT) counterpart. 
These findings might well correlate with SOCE dysregulation and altered cytosolic and ER Ca2+ 
levels. Indeed, increased SERCA levels could not be sufficient to restore normal resting ER Ca2+ 
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levels in hSOD1(G93A) astrocytes in light of the notion that PMCA overexpression might cause an 
overall reduction of cell (and ER) resting Ca2+ concentrations25. 
It is largely accepted that mitochondria play a critical role in buffering cell Ca2+ by actively taking 
up the ion in the mitochondrial matrix through the recently discovered mitochondrial Ca2+ uniporter 
(MCU) complex located in the inner mitochondrial membrane, and thanks to the sustained 
mitochondrial membrane potential (m)26. Furthermore, mitochondrial dysfunctions (also in 
astrocytes) were repeatedly correlated to ALS pathogenesis6,27,28. In light of this notion, we 
controlled the calcium uptake capability of mitochondria after SOCE stimulation in primary spinal 
cord astrocytes of hSOD1(G93A) and hSOD1(WT) mice (Fig. 7). No difference was found between 
hSOD1(G93A) and hSOD1(WT) primary spinal cord astrocytes, which is leading to assume that 
mitochondrial calcium uptake does not contribute to excess cytosolic calcium concentration after 
SOCE stimulation in hSOD1(G93A).  
Subsequently, because m is the driving force for mitochondrial Ca2+ uptake, we compared m 
using the potentiometric probe tetra-methylrhodamine methyl ester perchlorate (TMRM) (a cell-
permeant, cationic, red-orange fluorescent dye that is readily sequestered by active mitochondria), 
in primary spinal cord astrocytes of hSOD1(G93A) and hSOD1(WT) mice (Fig. 8). The 
fluorescence signal of TMRM can be directly correlated to m across the inner mitochondrial 
membrane29. We found that hSOD1(G93A) astrocytes do not show significant variations in m, 
suggesting no bioenergetic abnormalities ALS astrocytes (Fig.8 A-B).  
We also analysed some other mitochondrial parameters, such as the mitochondrial morphology an 
distribution and the expression of the MCU Ca2+ uniporter (Fig. 9, Fig. 10). Mitochondrial 
morphology was quantified in cells ectopically expressing the mitochondrial red fluorescent protein 
mtRFP (Fig. 9A). Evaluation of mitochondria circularity (index of elongation) revealed no 
difference between the two hSOD1 genotypes. 
MCU is a calcium transporter that localizes to the mitochondrial inner membrane and allows the 
mitochondrial uptake of calcium ions: in our experimental setting, no different was observed 
between hSOD1(G93A) and hSOD1(WT) astrocytes (Fig. 10). It is worth noting, however, that the 
complex regulation of MCU activity, implicating other complex subunits (i.e., MICU1-2, EMRE) 
demands for further analysis on this topic. 
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Together, these results indicate that mitochondria play a minor role, if any, in regulating cell Ca2+ 
levels, and that no abnormality in mitochondrial bioenergetics, morphology and MCU expression 
occurs in primary spinal cord astrocytes carrying the ALS-related hSOD1(G93A) mutant.  
In summary, the above results demonstrate that hSOD1(G93A)-expressing astrocytes have 
enhanced SOCE-mediated Ca2+ influx from the extracellular space into the cytosol and the ER 
lumen, most probably due to increased formation of STIM1 punctae at the PM15. This mechanism is 
also associated the SERCA over-expression of in hSOD1(G93A) astrocytes, which – however – is 
not sufficient to counteract ER basal Ca2+ depletion, possibly because increased PMCA expression 
functionally predominates25. In this scenario, mitochondria seem to have a minor role in regulating 
cytosolic Ca2+ levels after SOCE stimulation in hSOD1(G93A) and control astrocytes. 
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5.3.2 Increase of Ca2+ release from the ER after ATP stimulation 
An important role in cell Ca2+ homeostasis of the nervous system is played by G-protein-coupled 
receptors (GPCRs), among which purinergic receptors are important regulators of neuronal 
development in the context of the neuron-glia interplay. For instance, GPCR activation on the PM is 
the major mechanism increasing cytosolic Ca2+ levels in astrocytes thanks to the activation of 
inositol trisphosphate (IP3) receptors (IP3Rs) on the ER membrane and consequent Ca
2+ release 
from the ER30. 
They express P2Y1, P2Y2, P2Y4, P2Y6, P2Y12, and P2Y14 metabotropic GPCRs31, but the 
signalling pathways controlled by these receptors are not completely understood. In light of the 
increased Ca2+ release from the ER during ATP stimulation reported in in hSOD1(G93A) astrocytes 
by Kawamata et al. (2014)15, we have focused our attention on astrocytic Ca2+ dynamics upon 
activation of purinergic receptors. 
Intracellular Ca2+ dynamics were evaluated by live-cell imaging, using AEQs targeted to the cytosol 
or the mitochondrial matrix and expressed by lentiviral vector systems, in response to purinergic 
receptor activation by ATP. We observed comparable Ca2+ transients in both cell compartments 
following stimulation with ATP in a Ca2+ (1 mM)-containing (data not shown) or a Ca2+-free 
medium (Fig.11 A,B), indicating that intracellular Ca2+ movements were caused by IP3R activation 
and release of the ion from the ER rather than entry from the extra-cellular space through ionotropic 
receptors. Such Ca2+ transients were higher in the cytosol of hSOD1(G93A) than in hSOD1(WT) 
astrocytes (Fig.11A), while – quite surprisingly – no difference was observed in the mitochondrial 
matrix (Fig.11B). 
To mechanistically explain this increase in ER Ca2+ release after ATP stimulation we performed 
preliminary experiments to estimate the expression of IP3R and some metabotropic purinergic 
receptors present in astrocytes. No significant difference was observed in IP3R and P2Y1 (Fig.12A, 
B), while P2Y6 is much more abundant in hSOD1(G93A) astrocytes than in hSOD1(WT) cells 
(Fig.12C). Given that this receptor is preferentially activated by UDP rather than ATP, other 
experiments are in progress, in which we are testing UDP or different ATP concentrations to 
stimulate astrocytes.  
Thus, to thoroughly investigate and better explain the molecular pathways that are behind these 
alterations in Ca2+ metabolism and protein expression, different approaches are presently being 
performed, including ATP dose-response experiments and dosing of IP3 in astrocytes with the two 
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hSOD1 genotypes. This last part of the work, however, is still in progress, and all hypotheses are 
not yet confirmed by statistical analyses. 
We want also try to restore Ca2+ peak value in hSOD1G93A astrocytes with a dosing of ATP 
stimulus in attempt to find a possible target for molecular drugs. These investigations will be 
complemented with by pharmacological approaches on Purinergic Receptor to assess whether their 
inhibition perturbs the overall astrocyte Ca2+ homeostasis in a way that depends on mSOD1 
expression. 
The exact mechanisms by which mutant SOD1 is toxic to MNs are not yet defined. In vitro ALS 
models, however, disclosed that expression of SOD1(G93A) in astrocytes induces extensive death 
of co-cultured spinal cord MNs11. Accordingly, primary MNs are also sensitive to the treatment 
with conditioned medium from astrocytes expressing mutant SOD. 
On the other hand, astrocytes form tripartite synapses with presynaptic and postsynaptic neuronal 
terminals, and actively modulate neuronal/synaptic functions by releasing (by Ca2+-regulated 
mechanisms) gliotransmitters such as glutamate, ATP, and D-serine. It is also recognized that, in 
ALS, astrocytes undergo a series functional alterations leading MNs to irrecoverable degeneration. 
For all this reasons, our findings of local Ca2+ dysregulation upon SOCE and purinergic stimulation 
in SOD1(G93A) astrocytes could pave the way to the understanding of cell mechanisms related to 
MN damage, and the identification of new biological targets for the development of therapeutical 
strategies. 
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5.4 Materials and Methods 
5.4.1 Animals & Mouse genotyping 
Please refer to “Animals” and “Mouse genotyping” in the previous part “Generation and validation 
of novel adeno-associated viral vectors for the analysis of Ca2+ homeostasis in motor neurons”. 
5.4.2. Primary cultures 
Primary cultures of spinal astrocytes were isolated from newborn mice and cultured as described in 
Martorana et al. (2012)7. Briefly, after extraction and dissection in Hank’s Buffer (Sigma), spinal 
cord was incubated (5’, 37°C) in the same solution added with Collagenase (0.25%). Threw the 
supernatant, the pellet was re-suspended in Hank’s Buffer with DNase (0.05%), mechanically 
dissociated, added with minimal essential medium (MEM, Gibco) supplemented with FBS 10% 
(v/v) and centrifuged (220 g, 5’). The pellet was re-suspended in complete medium [MEM 
supplemented with FBS 20% (v/v), L-glutamine 2 mM, glucose in phosphate buffered saline (PBS) 
0.3% (w/v), penicillin 100 U/ml, streptomycin 100 µg/ml] and seeded. Once the cultures reached 
the confluence (three weeks), they were re-plated at the optimal density 80.000 cells/well in 24-well 
plates (AEQcyt, AEQmt and AEQpm measurements) or 160.000 cells/well in 12-well plates 
(cameleon measurements) containing glass coverslips and maintained in complete medium. For 
AEQER measurements cells were re-plated at the optimal density 12.000 cells/well in 96-well plates 
and maintained in the same medium.  
Cultures purity was proved by immunocytochemical test and was at (at least) >97% . 
Lentiviral particles (see below for the production), AEQpm, AEQcyt, AEQmt and AEQER, were added 
to astrocytes 24 h after plating and after further 72 h were used for experiments. 
5.4.3 Immunocytochemistry 
For immunocytochemical analysis, astrocytes (96h in vitro) were firstly washed in ice-cold PBS, 
and then fixed (20 min, RT) in paraformaldehyde [PFA, 4% (w/v)] in PBS. After washing in PBS, 
cells were permeabilized in PBS containing Triton X-100 [1 h, RT, 0.02% (w/v)] and then 
incubated (overnight, 4 °C) with rabbit anti-GFAP polyclonal (p) Ab (1:500, Dako) and mouse anti-
HA monoclonal (m) Ab (1:500, Covance). After extensive washings in PBS, cells were incubated 
(1 h, 37 °C) respectively with the secondary antibodies rhodamine-conjugated anti-rabbit IgG 
(1:100, Dako) and Alexa Fluor 555-conjugated anti-mouse IgG (1:500, Molecular Probes). Cell 
nuclei were counter-stained with Hoechst 33342 (5 μg/ml, Sigma), and coverslips were finally 
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washed in PBS, mounted in montage solution [8% Mowiol 40-88 (Sigma) in glycerol and PBS (1:3 
(v/v)], and observed with an inverted fluorescence microscope (Leica CTR6000) equipped with a 
computer-assisted charge-coupled camera (Orca Flash 4.0, Hamamatsu), or with a confocal 
microscope system (Leica TCS-SP5), which also allowed the acquisition and analysis of digital 
images. 
5.4.4. Construction of lentiviral vector 
To follow Ca2+ fluctuations in specific astrocytes compartments, we exploited a lentiviral 
expression system to transduce cells with chimeric constructs encoding the Ca2+-probe aequorin 
(AEQ) tagged with the influenza virus hemagglutinin (HA) epitope, and linked to sequences 
addressing the protein to the cytosolic domains proximal to the PM (AEQpm)
32, the cytosol 
(AEQcyt)
33, the ER lumen (AEQER)
34, and the mitochondrial matrix (AEQmt)
35. Lentiviral vectors for 
AEQpm, AEQER and AEQmt were generated as described
36,37, using an AEQ mutant with reduced 
Ca2+ affinity that allows measurements of [Ca2+] >10 µM38. 
Conversely, to detect variations of cytosolic [Ca2+], a chimeric construct of WT AEQ fused to the 
monomeric red fluorescent protein (mRFP) was used. To generate the AEQcyt lentiviral vector, two 
PCR reactions were performed. In the first PCR, the mRFP sequence was amplified without the 
stop codon using the pCDNA3-mRFP plasmid (Clontech) as template, and the following primers: 
XbaI-mRFP (forward, CGTCTAGAATGGCCTCCTCCGAGGAC)  
mRFP-BglII (reverse, GAGGCGCCGGTGGAGTGGAGATCTCG) 
In the second PCR, the HA-AEQ cassette was amplified using the pCDNA1-AEQcyt plasmid33 as 
template, and the following primers: 
BglII-AEQ (forward, CGAGATCTCGAGCTCAAGCTTTATGA)  
AEQ-SalI (reverse, GGTATCGATAAGCTTGATGTCGACGC). 
PCR products were digested with XbaI and BglII for mRFP and with BglII and SalI for HA-AeQ, 
and the resulting fragments were assembled into the XbaI- and SalI-digested backbone of the 
lentiviral vector pRRLsin.PPTs.hCMV.GFP.pre, in a three-step ligation reaction. 
Lentiviral particles were produced as described in Ramezani et al. (2002)39. Briefly, HEK293T 
packaging cells (2 x 106 cells in 100 mm culture plates), cultured in Dulbecco’s modified Eagle’s 
medium (Sigma) supplemented with FBS 10%, L-glutamine 2 mM, penicillin 100 U/ml, 
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streptomycin 100 µg/ml (Euroclone), were co-transfected (24 h after plating), by means of the 
calcium-phosphate transfection method, with plasmids: 
● pMD2.VSVG encoding for the envelope pseudo-typing; 
● pMDLg/pRRE packaging plasmid that includes gag, coding for the virion main structural 
proteins, and pol, responsible for the retrovirus-specific enzymes; 
● pRSV-REV, Rev cDNA expressing plasmid in which the joined second and third exons of 
HIV-1 rev are under the transcriptional control of RSV U3 promoter. Encoding for the protein REV 
for the expression of gag and pol;  
● pLV-AEQ construct. 
After 14 h, the transfection medium was replaced with fresh culture medium, and cells were grown 
for 72 h, after which the culture medium was collected. Viral particles were harvested by 
ultracentrifugation (50,000 g, 2 h), re-suspended in 0.2 mL of phosphate buffer saline (PBS), and 
stored at -80 °C until use. 
5.4.5. Ca2+ imaging_Aequorin 
All experiments with AEQpm, AEQcyt and AEQmt were performed by means of a computer-assisted 
luminometer equipped with a perfusion system (1). For AEQER was used EnVision
TM Multilabel 
Plate Reader (Perkin Elmer) (2). Depending on the type of measurement, cells were treated as 
described follow.  
1. To measuring Ca2+ movements elicited by SOCE with AEQpm, AEQcyt and AEQmt, 
astrocytes were incubated (1 h, 37 °C, 5% CO2) in a modified Krebs-Ringer buffer [(KRB, 
NaCl 125 mM, KCl 5 mM, Na3PO4 1 mM, MgSO4 1 mM, glucose 5.5 mM, HEPES 20 mM 
(pH 7.4)] supplemented with EGTA (100 µM, to deplete Ca2+ from cells), and 
coelenterazine (5 µM, Santa Cruz). After transferring the cell-containing coverslip to the 
thermostatted chamber of the luminometer, experiments started by perfusing cells with 
KRB, first containing EGTA (100 µM), then CaCl2 (1 mM).  
To monitor Ca2+ fluxes elicited by activation of purinergic receptor with AEQcyt and AEQmt, 
astrocytes were incubated (1 h, 37 °C, 5% CO2) in a modified KRB supplemented with 
CaCl2 (1 mM), and coelenterazine (5 µM). After transferring the cell-containing coverslip to 
the thermostatted chamber of the luminometer, experiments started by perfusing cells with 
KRB, first containing EGTA (100 µM), then ATP (100 µM) with/o CaCl2 (1 mM). 
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2. When measuring [Ca2+]ER, astrocytes were washed three times with KRB supplemented 
with EGTA (1 mM), left 10 min at 37 °C (CO2 5%), and incubated (1 h, 4 °C) in KRB 
supplemented with ionomycin (5 µM, Sigma), EGTA (500 µM) and a modified 
coelenterazine (coelenterazine n, 5 µM, Sigma), whose reduced Ca2+ affinity allows 
detection of high [Ca2+]ER, in the end washed three times with KRB supplemented (in 
sequence) with: EGTA (500 µM); 2% (w/v) BSA and EGTA (1 mM) ; EGTA (500 µM). 
After transferring the plate into EnVisionTM Multilabel Plate Reader (Perkin Elmer), 
experiments started by adding KRB containing CaCl2 (1 mM). It is to be noted that, despite 
few different steps, the procedure to deplete ER Ca2+ store ensured that astrocytes were 
subjected to similar conditions to those employed when measuring [Ca2+] in the other tested 
domains before SOCE. 
All experiments ended by lysing cells with digitonin (100 μM, Sigma) in a hypotonic Ca2+-rich 
solution (CaCl2 10 mM in H2O) to discharge the remaining AEQ pool. The light signal was 
digitalized and stored for subsequent analyses. Luminescence data were calibrated off-line into 
[Ca2+] values, using a computer algorithm based on the Ca2+ response curve of AEQ33. 
5.4.6. Measurement of mitochondrial membrane potential 
The membrane potential of astrocytes mitochondria (Δψm) was measured using the (PM-
permeable) cationic tetramethylrhodamine methyl ester probe (TMRM, λexc = 548 nm, λem = 574 
nm), which accumulates electrophoretically into the mitochondrial matrix. 
To analyse Δψm, astrocytes were incubated (30 min, 37°C, CO2 5%) with TMRM (10nM, 
Molecular Probes) in KRB containing CaCl2 (1 mM) and finally in Mg
2+ free-KRB. Coverslip 
images were collected with an inverted microscope (Olympus IMT-2) equipped with a (75W) 
xenon lamp to provide fluorescence light, a 16 bit digital cooled CCD camera (provided with a 
cooling system Miromax, Princeton Instruments), a 40X oil objective, and appropriate excitation 
and emission filters. Several fields were acquired from each coverslip before and after addition of 
trifluorocarbonylcyanide phenylhydrazone (FCCP) (5 μM, Sigma) that, by collapsing the Δψm, 
releases the probe from mitochondria.  
Images were analysed using the Image J software. Fluorescence intensity was measured in regions 
rich in mitochondria. For each analysed coverslip, the TMRM fluorescence intensity was calculated 
as the difference between the mean fluorescence intensity before and after of FCCP addition. 
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5.4.7. Analysis of Mitochondrial Morphology 
Primary astrocytes were transiently transfected (Lipofectamine 3000, Life Technologies, according 
to manufacture) with mtRFP 24h after plating. After 72h cells were observed under confocal 
microscope system (Leica TCS-SP5) to evaluate mitochondrial morphology fluorescence. In 
particular, when cells exhibit a network of filamentous mitochondria usually are classified as 
normal (not fragmented), and cells with fragmented or partially truncated mitochondria are 
classified as fragmented. To calculate mitochondrial shape, fluorescence microscopy images of 
randomly selected fields were acquired (at least 10 fields for each coverslip), and every single 
mitochondrion of the investigated cells was marked to analyse morphological characteristics such as 
its area, perimeter, and major and minor axes. On the basis of these parameters, the mitochondrion 
circularity and its form factor (4π × area/perimeter2), consistent with a measure of mitochondrial 
length and the degree of branching, were calculated as described in Dagda et al. (2009)40.  
5.4.8. Western Blot Analysis 
 Sample preparation 
Astrocytes, 96 hours  after plating, were homogenized in a buffer containing glycerol 10% 
(w/v), SDS 2% (w/v), Tris/HCl 62.5 mM (pH 6.8), urea 1.8 M, NaVO4 5 mM, protease and 
phosphatase inhibitor cocktails (Roche), and boiled (5 min). The total protein content was 
determined by the Lowry method (Total Protein Kit, Micro Lowry, Peterson’s Modification, 
Sigma), using BSA as standard. Dithiothreitol (50 mM) and bromophenol-blue (0.004% 
(w/v)) were added to samples just before gel loading. 
 SDS-polyacrylamide gel electrophoresis (SDS-Page) and immunoblot 
Electrophoresis was performed on precast gels 4-15% (Bio-Rad) and run with a buffer  
containing 0.1 M Tris-HCl, 0.77 M glycine and 0.4% SDS, pH 8.3. 
Samples (18 μg of proteins in each lane) were run on the gel using an Electrophoresis Power 
Supply (BioRad), providing a constant voltage of 150 V in the stacking gel and 200 V in the 
separating gel. Proteins were then electro-blotted onto PVDF membranes (0.22 μm pore 
size, Bio-Rad). Membranes were incubated (1 h, RT) with a blocking solution of non-fat dry 
milk 5% (w/v), or BSA 3% (w/v) in Tris Buffer Saline added with 0.1% TWEEN 20 (w/v) 
(TBS-T), and followed by addition of the appropriate primary antibody (see below) (4 °C, 
over-night). After three 10 min-washes (with TBS-T), membranes were incubated (1 h, RT) 
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with a horseradish peroxidase-conjugated anti-rabbit or anti-goat IgG secondary antibody 
(Santa Cruz Biotechnology). 
Used antibodies were (dilution in parentheses): rabbit anti-STIM1 pAb (1:1000; Cell 
Signaling Technology);  rabbit anti-STIM2 pAb (1:1000; ProSci Inc); rabbit anti-ORAI1 
pAb (1:1000; Abcam); rabbit anti-ORAI3 pAb (1:1000; Thermo Fisher Scientific); goat anti 
SERCA pAb (1.1000; Santa Cruz Biotechnology); rabbit anti MCU pAb (1.1000; Sigma 
cat.n. HPA016480); rabbit anti IP3R pAb (1.1000; calbiochem); rabbit anti PMCA pAb 
(1.1000; Santa Cruz Biotechnology); rabbit anti P2Y6 pAb (1.1000; alomone labs); rabbit 
anti P2Y1 pAb (1.1000; Abcam), rabbit anti CRT pAb (1.1000; Abcam), rabbit anti CNX 
pAb (1.1000; Abcam), rabbit anti GRP78 pAb (1.1000; Abcam). 
Immunoreactive bands were visualized and digitalized by means of NineAlliance (UVITEC 
Cambridge), using an enhanced chemiluminescence reagent kit (Millipore Corporation). For 
densitometric analyses, band intensities were normalized to the optical density of the 
corresponding lane stained with Coomassie blue. 
5.4.9. Statistical analysis 
For aequorin analysis values will be reported as mean ± SEM. Data analysis was performed as 
described in Lazzari et al. (2011).  
Statistics for all the experiments were based on two-sample Student’s t-test, with a p-value <0.05 
being considered statistically significant (**p<0.01, ***p<0.001). 
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5.6 Legends to Figures 
Figure 1. Experimental setting for astrocyte culturing. Primary cultures of spinal astrocytes were 
isolated from hSOD1(WT) and hSOD1(G93A) newborn (P 0-1) mice and cultured for 3 weeks until 
cultures reached the confluence. Subsequently, they were re-plated at an optimal density (80.000 
cells/well) in 24-well plates containing glass coverslips and maintained as described previously 
(Martorana et al. 2012; see also Materials and Methods). The day after plating, cells were 
transfected with the AAV9-cmv-cyt or AAV9-cmv-mt or AAV9-cmv-ER plasmidic vectors 
encoding the cameleon probes and used for experiments 72 h later. For cell transduction with the 
different AEQ isoforms, cells were infected with lentiviral particles (coding for AEQpm, AEQcyt, mt-
AEQmit and AEQER) 24 h after plating, and after further 72 h they were used for experiments. The 
same protocols for generation and culturing of spinal astrocytes was used for the measurement of 
mitochondrial membrane potential, WB and immunofluorescence analyses, and for mitochondrial 
morphology assessments. 
Figure 2. Primary cultures were almost pure in astrocytes and were efficiently transduced 
with the AEQ probes. Panels A-C. 4 DIV primary spinal astrocytes were fixed and fluorescence 
immunostained with an antibody to the astrocytic marker GFAP (A, red signal), then counterstained 
with the dye Hoechst 33342 marking all nuclei (B, blue signal), and observed with a fluorescence 
microscope. Merge of the two images (C) and the below bar diagram, reporting the percentages of 
GFAP-negative (black bar) and -positive (red bar) cells, indicate that the astrocytic cultures did not 
suffer from significant contamination by other cell types. Panels D-E. Primary astrocytes transduced 
with a lentiviral vector coding for AEQmit, were immunostained for AEQ (D, green signal) and the 
astrocytic marker GFAP (E, red signal), indicating that the Ca2+ probe was effectively expressed in 
astrocytes. Data reported in the bar diagram are mean  standard error of the mean (SEM), n = 45; 
***p < 0.001, two-way Student’s t-test. Scale bar = 50 µm in A-C; 20 µm in D-E. 
Figure 3. Altered Ca2+ transients in fALS primary astrocytes compared to controls. 
hSOD1(WT) (black) or hSOD1(G93A) (red) primary spinal astrocytes were transduced with 
lentiviral vectors encoding AEQPM (A) or AEQcyt (B) targeted to sub-PM microdomains or bulk 
cytosol, respectively, and [Ca2+] fluctuations after SOCE stimulation were recorded in such cell 
compartments. For SOCE stimulation, astrocytes were first incubated in a Ca2+-free buffer 
containing EGTA (100 μM), and then perfused with CaCl2 (1 mM), as indicated by arrows. The 
with-time average of the recorded traces is reported in left panels, while bar diagrams on the right 
report the peak values of Ca2+ transients. This data indicates that hSOD1(G93A) astrocytes have 
higher Ca2+ influx following SOCE than hSOD1(WT). Here and after, reported values are mean ± 
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SEM, numbers inside bars indicating the number of replicates (n). Peak values are: in PM 
microdomains, 19.97 ± 1.10 μM in hSOD1(G93A), 15.65 ± 1.11 μM in hSOD1(WT); in the 
cytosol, 1.40 ± 0.07 in hSOD1(G93A), 1.15 ± 0.03 μM in hSOD1(WT). ***p<0.001, two-way 
Student’s t-test. 
Figure 4. Higher ER Ca2+ refilling in fALS primary astrocytes compared to controls. 
hSOD1(WT) (black) or hSOD1(G93A) (red) primary spinal astrocytes were transduced with 
lentiviral vectors encoding AEQER targeted to the ER, and ER Ca
2+ replenishment was recorded 
following intracellular Ca2+ store depletion (by incubation in EGTA 500 μM and the Ca2+ 
ionophore ionomycin (5 μM), in a Ca2+-free buffer) and subsequent SOCE activation (by treatment 
with CaCl2 1 mM), as indicated by arrows.The with-time average of the recorded traces reported in 
the left panel, and the bar diagram on the right reporting the ER peak values, indicate that ER Ca2+ 
uptake following SOCE is higher in hSOD1(G93A) than in control astrocytes. Peak values are: 
338.47 ± 28.91 μM in hSOD1(G93A), 233.95 ± 16.61 μM in hSOD1(WT). Other experimental 
details are as in the legend to Figure 3. 
Figure 5. No significant difference is observed in the expression of major SOCE-related 
proteins in astrocytes with the two hSOD1 genotype. Astrocyte lysates were analysed by 
Western blot for the expression of proteins belonging to the SOCE molecular machinery (i.e., 
ORAI1 and ORAI3, STIM1-2). In each panel, the upper figure reports a representative WB of the 
protein of interest (run at least in duplicate), while the lower bar diagram reports the densitometric 
analysis of immunoreactive bands normalized to the optical density of the corresponding Coomassie 
blue-stained lane, and reported as fraction of the mean value obtained with hSOD1(WT) astrocytes. 
No significant difference was observed in the expression of any of the analysed molecular SOCE 
components. Other experimental details are as in the legend to Figure 3. 
Figure 6. hSOD1(G93A)-expressing astrocytes express comparable levels of ER stress-related 
proteins, but higher amounts of both SERCA and PMCA pumps. Protein extracts from 
astrocytes were analysed by Western blot for the expression of Ca2+-dependent ER stress markers 
(i.e., calnexin (CLNX, panel A), calreticulin (CRT, panel B) and the unfolded protein response 
regulator GRP78, panel C) and of the sarco-endoplasmic reticulum and PM Ca2+ ATPases (SERCA 
and PMCA, panels D and E, respectively). While no significant difference was observed in the 
expression of ER stress-related proteins, both SERCA and PMCA were upregulated in fALS 
astrocytes compared to the healthy counterpart. ***p<0.001, two-way Student’s t-test. Other 
experimental details are as in the legend to Figure 5. 
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Figure 7. No difference is observed in SOCE-evoked mitochondrial Ca2+ transients in primary 
astrocytes with different hSOD1 genotype. Ca2+ fluxes induced by SOCE were measured in 
hSOD1(WT) (black trace) or hSOD1(G93A) (red trace) by means of lentivirally-delivered AEQmit. 
Both the average traces reported on the right and the peak values reported in the bar diagram 
provide comparable results for the two astrocyte populations. Peak values are: 15.76 ± 1.38, 
hSOD1(G93A); 13.88 ± 1.09 μM in hSOD1(WT). Other experimental details are as in the legend to 
Figure 3. 
Figure 8. No significant difference is observed in m between fALS and healthy astrocytes. 
Primary astrocytes were loaded with the potentiometric fluoro-probe TMRM that is suited for 
comparing the mitochondrial membrane potential (m) between two populations of cells, whereby 
a decrease in TMRM fluorescence reflects mitochondrial depolarization. Representative images of 
TMRM-loaded astrocytes, before and after FCCP addition, are shown on the left panel, while the 
bar diagram on the right reports the quantitative fluorescence analysis (see Materials and Methods) 
indicating no difference in the mitochondrial polarisation between the two hSOD1 genotypes. 
Reported values are mean ± SEM; numbers inside bars indicate the number of coverslips. 
Figure 9. No significant difference is observed in mitochondrial morphology between fALS 
and healthy astrocytes. Primary astrocytes were transfected with plasmidic vectors coding for a 
mitochondria-targeted red fluorescent protein (mtRFP), to assess mitochondria 
morphology/distribution by fluorescence microscopy. Representative fluorescence images of 
mtRFP-expressing astrocytes (72 h after transfection) are reported on the left, while the bar diagram 
on the right report the quantification of mitochondrial circularity (see Materials and Methods) 
showing no difference between the two hSOD1 genotypes. Other experimental details are as in the 
legend to Figure 8. 
Figure 10. The Ca2+ channel-forming subunit of the mitochondrial Ca2+ uniporter (MCU) 
complex is equally expressed in astrocytes with the two SOD1 genotypes. Astrocyte lysates 
were analysed by Western blot for MCU expression, as shown in the upper representative WB of 
the protein (run in duplicate for each genotype), and the lower bar diagram reporting the 
densitometric analysis of MCU immunoreactive bands. Experimental details are as described in the 
legend to Figure 5. 
Figure 11. Primary fALS astrocytes have higher ATP-evoked Ca2+ transients in the cytosol 
(but not in mitochondria) than the healthy counterpart. hSOD1(WT) (black) or hSOD1(G93A) 
(red) primary spinal astrocytes were transduced with lentiviral vectors encoding AEQcyt (panel A) 
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or AEQmit (panel B), and Ca
2+ transients in the two cell compartments were measured following 
ATP stimulation in the absence of extracellular Ca2+. To this purpose, cells were briefly (10 s) 
perfused with a Ca2+-free, EGTA (100 mM)-containing buffer, and then treated with a Ca2+-free 
solution containing ATP (100 M). Under these conditions, ATP-evoked Ca2+ transients were 
specifically determined by Ca2+ release from intracellular (ER) stores. Such a stimulation protocol 
results in a higher cytosolic Ca2+ rise in hSOD1(G93A) astrocytes than in controls, as shown by the 
average traces of the left panel, and the Ca2+ peak values reported in the bar diagram on the right 
(A). Conversely, no difference is observable in mitochondria (B), suggesting that the organelles 
have a negligible role in the alterations of Ca2+ homeostasis induced by mutant hSOD1. Similar 
Ca2+ transients were observed when ATP stimulation was carried out in the presence of 
extracellular Ca2+ (1 mM), indicating that ionotropic purinergic receptors do not contribute to the 
observed Ca2+ mobilisation. Peak values are: 2.60 ± 0.05 μM in hSOD1(G93A); 1.98 ± 0.04 μM in 
hSOD1(WT), in the cytosol; 40.18 ± 2.95 μM in hSOD1(G93A); 38.92 ± 2.33 μM in hSOD1(WT), 
in the mitochondrial matrix. ***p<0.001 by two-way Student’s t-test. Other experimental details are 
as in the legend to Figure 3. 
Figure 12. Primary fALS astrocytes express much more P2Y6 receptor, but equal amounts of 
IP3 or P2Y1 receptors, compared to control cells. 96 h from plating, astrocytes were collected 
and lysed, and protein extracts were subjected to Western blot analysis for the expression of IP3R 
(A) or the purinergic metabotropic receptors P2Y6 (C) or P2Y1 (B). The upper part of each panel 
reports a representative WB of the protein of interest (run at least in duplicate for each hSOD1 
genotype) and the corresponding Coomassie-stained lanes, while the lower bar diagram reports the 
densitometric analysis of immunoreactive bands. While no difference was observed for IP3 and 
P2Y1 receptors, a significantly higher expression of P2Y6 receptors is evident in hSOD1(G93A) 
astrocytes compared to hSOD1(WT) cells. ***p<0.001, two-way Student’s t-test. Other 
experimental details are as in the legend to Figure 5. 
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